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DISSERTATION ABSTRACT 
 
James John Hannigan 
 
Doctor of Philosophy 
 
Department of Human Physiology 
 
September 2017 
 
Title: Neuromuscular Control of the Hip, Pelvis, and Trunk During Running 
 
 
Patellofemoral pain syndrome (PFPS) is the most common injury in runners and 
has a significant female sex bias.  Current evidence suggests that several proximal 
factors, including hip muscle strength, hip muscle activation, and hip kinematics during 
running, play a large role in the development of PFPS, particularly in females.  However, 
the relationships between these variables are unclear.  A better understanding of these 
relationships in both males and females could help clinicians develop targeted 
interventions for this syndrome.  Thus, this dissertation is comprised of four studies 
aimed to better understand the relationships between these risk factors. 
 The first study investigated whether there are any relationships between hip 
muscle strength and hip muscle activation during running.  Overall, hip muscle strength 
and hip muscle activity during running do not appear to be strongly related.    
The second study used a multiple regression approach to look for predictors of hip 
adduction and hip internal rotation during running.  Sex was a significant predictor in 
both models, and running speed, static subtalar inversion range of motion, and gluteus 
maximus amplitude were significant predictors in the hip adduction model. 
 The third study examined the effect of decreasing hip abduction strength on 
running kinematics and hip muscle EMG.  After the fatigue protocol, there were no 
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changes in gluteus medius amplitude or timing, and no changes in hip kinematics during 
running.  However, there were some changes in kinematics, particularly at the trunk, as 
well as differences in gluteus maximus and tensor fascia latae activation. 
 Finally, the fourth study used an alternative biomechanical method called 
continuous relative phase (CRP) to investigate the effect of sex and decreasing hip 
abduction strength on CRP variability at the hip.  Decreasing hip abduction strength 
increased frontal plane CRP variability from 20-40% of stance phase, primarily in females, 
and females demonstrated less CRP variability than males in the frontal plane and 
transverse planes. 
 Overall, the results from this study improve our understanding of the relationships 
between hip strength, hip muscle activation, and hip kinematics during running in both 
males and females, which may have implications for knee injury rehabilitation strategies. 
 
This dissertation includes unpublished co-authored material. 
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CHAPTER I 
INTRODUCTION 
 
Health Benefits and Risks of Running 
 According to the World Health Organization, approximately 68% of deaths each 
year are due to non-communicable chronic diseases such as cardiovascular disease, type 
2 diabetes, cancer, and chronic respiratory disease (124).  The five leading risk factors for 
these diseases are high blood pressure, tobacco use, high blood glucose, physical 
inactivity, and obesity (9).  Physical inactivity itself has been linked to high blood 
pressure, high blood glucose, and obesity, meaning a low level of physical activity is 
either directly or indirectly related to four of the five top risk factors for chronic disease 
(9). 
 Running is a very popular method of physical activity.  Regular running is 
associated with improved aerobic fitness, cardiovascular function, metabolic fitness, 
adiposity, and postural balance (83).  In the United States alone as of 2013, almost 10 
million people reported running at least 110 days per year, with an additional almost 20 
million running between 25-109 days per year (73).  This accounts for approximately 15-
20% of the United States’ population (33,73).  From 2004 to 2013, running participation 
has increased by about 70% in the United States (73).  While this increase in running 
participation may help combat the rise of chronic diseases (9), running comes with its 
own set of risks – namely, injury. 
 Depending on the competitive level of runners sampled and definition of injury, 
somewhere between 20 to 80% of runners will develop an injury over the course of a year 
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(38), meaning approximately 6 to 24 million runners are injured annually.  Between 40-
70% of injured runners seek medical treatment for these injuries (55,68), meaning that 
high medical costs are associated with these injuries.  Many runners seek treatment 
because these injuries not only prevent them from participating in physical activity, but 
also interfere with activities of daily living and general quality of life (38). 
 Running injuries are predominantly multifactorial in nature (38,56).  While 
studies vary slightly in how these risk factors are grouped, most studies agree that all 
injuries can be traced to some combination of training, systemic, health/lifestyle, and 
physiologic factors (12,38,49,77).  While most factors within these subgroups are specific 
to a particular injury, a couple factors are common amongst all injuries: training errors 
and previous injuries. 
Training errors, although arguably the most modifiable factor, appear to be the 
biggest culprit, responsible for up to 60% of all running injuries (56). These training 
errors include excessive mileage, intense workouts, a sudden change in training, and 
running on hills or hard surfaces (49,56,77).  While most runners understand that training 
errors are a significant risk factor for injury, many admit they do not heed proper training 
precautions to prevent injury (94).  Thus, encouraging runners to modify their training 
program should be an important emphasis for clinicians when releasing runners to resume 
their training after a setback (49,56). 
Another very important risk factor, part of the health/lifestyle subgroup, is having 
sustained a previous injury, which has been shown to significantly increases one’s 
susceptibility to incurring a subsequent injury (12,49,67).  While resuming training too 
quickly may be a common factor in re-injury, another possibility is that one or more of 
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the underlying causes of injury was not addressed during rehabilitation (90).  Many of 
these underlying causes fall into the physiologic category of factors, which includes 
muscle strength, flexibility and range of motion, muscle activation patterns during 
running, and running biomechanics.   
Research on these physiologic factors has grown exponentially over the past 10 
years, especially for injuries to the knee, which account for 40-50% of all running injuries 
(38,56,106).  Of these knee injuries, patellofemoral pain syndrome (PFPS) has received 
the most attention, since it is considered the most common yet enigmatic running-related 
injury (106).  Understanding the relationship between several risk factors for this injury 
serves as the backbone of this project, and will be discussed further in the next section. 
 
Patellofemoral Pain (PFPS): Definition and Risk Factors 
Definition and Prevalence 
According to the 2016 Patellofemoral Pain Consensus Statement the core criterion 
in defining patellofemoral pain is “pain around or behind the patella, which is aggravated 
by at least one activity that loads the patellofemoral joint during weight bearing on a 
flexed knee” (17).  Crepitus, tenderness, effusion, or pain during sitting can be present, 
but are not essential for a diagnosis of patellofemoral pain (17).  Regardless, PFPS is the 
most common injury in runners, accounting for roughly 16-20% of all running-related 
injuries (106).  It is a particularly important injury to study, as mounting evidence 
suggests that developing patellofemoral pain early in life increases the risk of developing 
patellofemoral osteoarthritis later in life (60,110,126).  The injury also has a significant 
sex bias, as females are almost twice as likely to develop PFPS compared to males (106). 
 4 
 
A General Proposed Mechanism of Injury 
The exact mechanism for patellofemoral pain is not clear, as it is likely a 
multifactorial injury without one consistent mechanism (19).  In general, the pain during 
running is thought to be caused by a combination of malalignment and/or maltracking 
(19), which can reduce the contact area between the patella and femur, increasing 
pressure in that area (91).  Due to running’s repetitive nature, this may overload either the 
subchondral bone, infrapatellar fat pad, peripatellar synovium, retinaculum, or patellar 
ligaments over time (19,36).  When these repetitive stresses overload a tissue’s ability to 
rebuild and recover, the structures where loads are the greatest may begin to degenerate, 
initiating a pain signal from joint mechanoreceptors (36).  This pain appears greatest 
during squatting, stair ascent and descent, sitting, and running (25). 
While this framework may help explain PFPS etiology broadly, the specific 
causes of malalignment or maltracking are only partially understood.  Likely, these 
causes are a combination of local, distal, and proximal factors, which may vary between 
subgroups of PFPS sufferers (19).   
Local Factors 
Locally, the utility of the quadriceps angle, or Q-angle, has been controversial, as 
there is conflicting evidence that static Q-angle influences PFPS susceptibility.  Pooled 
data from a 2013 meta-analysis, however, did in fact show that PFPs sufferers on average 
displayed a significantly larger Q-angle compared with controls (59).  Greater lateral 
translation (24,122), lateral tilt (24,59,122), and hypermobility (123) of the patella may 
also predispose an individual to developing PFPS by affecting the normal alignment and 
arthrokinematics of the patellofemoral joint.  However, these local factors can only 
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partially explain the causes of patellar maltracking (91), as the knee joint mechanics are 
largely influenced by factors both distal and proximal to the joint.  Thus, both distal and 
proximal factors have been studied fairly extensively in relation to this injury.  
Distal Factors 
Despite extensive research, significant evidence pointing to distal factors is fairly 
limited.  Starting at the foot, pooled meta-analysis data does not support a relationship 
between arch height and PFPS (74).  In addition, although foot orthoses may help 
decrease knee pain during running (74), pooled data suggest there are no differences in 
peak rearfoot eversion between healthy and injured runners (22,75,80,81).  One study did 
find greater shank internal rotation in the PFPS group compared to controls, but 
suggested that this finding may be linked to more proximal factors in their discussion 
(81).  Thus, research over the past few 10 years has largely shifted to focusing on 
proximal factors, which have yielded more promising results.   
Proximal Factors 
Moderately strong retrospective evidence suggests that female runners with PFPS 
run with greater peak hip adduction (74,80–82,115,119) and peak hip internal rotation 
(81,82,101) compared to healthy female controls.  Limited prospective evidence also 
indicated that females who subsequently developed PFPS ran with greater peak hip 
adduction at pre-injury baseline compared to females who did not sustain an injury (80).  
In addition to the hip, there is moderate evidence of greater contralateral pelvic drop 
(74,119) and knee varus (119) in males with patellofemoral pain, and weak evidence that 
females with PFPS may display greater contralateral trunk lean (81) compared to 
controls. 
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A major takeaway from these studies is that females and males with PFPS display 
markedly different proximal and local kinematics, which would appear to have opposite 
effects on the both the Q-angle and patellar tracking.  Greater hip adduction, seen in 
female with PFPS, increases the Q-angle, and likely increases lateral patellar translation, 
which is thought to increases lateral patellofemoral joint stress (8,36). Conversely, 
increased knee varum, as seen in males, decreases the Q-angle, increasing medial patellar 
translation and likely medial patellofemoral joint stress (8,36).  These findings are 
interesting, as females are already noted to run with greater hip adduction (31) and hip 
internal rotation (31,96) compare to males when healthy.  These potential differences in 
etiology between sexes are noteworthy, especially considering the female sex bias of this 
injury.  However, the lack of information on PFPS in males, particularly the void of 
prospective research, prevents any concrete conclusions.  
In addition to kinematics, proximal muscle strength at the hip appears to be 
related to PFPS risk.  Strong evidence from several retrospective studies has 
demonstrated that females with PFPS displayed significantly weaker hip abduction 
strength (11,23,52,71,93,101), hip external rotation strength (11,52,71,93), and hip 
extension strength (93,101) compared to healthy controls while injured.  In addition, 
moderate evidence from retrospective studies suggests that females with PFPS displayed 
significantly weaker hip abduction strength (16,78,111), hip external rotation strength 
(16), and hip flexion strength (16,78) compared to the unaffected limb.  While 
prospective research is limited, Finnoff et al. (34) did find that runners who developed 
PFPS displayed significantly weaker hip abductors and external rotators post-injury 
compared to their healthy pre-season measurements.  It is important to note that a few 
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studies found no significant differences between injured runners and controls in regard to 
hip abduction and external rotator strength, both retrospectively (87) and prospectively 
(109). However, both of these studies measured muscle strength in testing positions that 
varied from standard procedures.  As for males, no study has found a significant 
difference in hip strength between males with PFPS and healthy controls, lending more 
evidence to a sex-specific etiology for this injury.  
 Proximal hip muscle activation also may be related to PFPS injury risk.  Willson 
et al. (117) found that females with PFPS displayed delayed and shorter duration gluteus 
medius activation compared to healthy controls.  In addition, this study found that 
delayed gluteus medius and gluteus maximus onset was significantly correlated with 
greater hip adduction excursion, while delayed gluteus maximus activation was 
significantly correlated with greater hip internal rotation excursion (117).  This finding 
thus appears to provide a link between the biomechanical and neuromuscular risk factors 
for this injury.  In addition, studies have found that females with PFPS run with greater 
peak gluteus maximus activation (101) and rearfoot strikers with PFPS (mixed sex 
cohort) run with less peak gluteus medius activation (27) compared to controls. 
 Based on these aforementioned results, proximal factors for PFPS appear to be 
very important and worth further investigation.  However, before exploring these factors 
further, it is important to discuss a different approach to running injury research that 
ignores individual risk factors and employs a more macroscopic technique. 
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Dynamical Systems Theory: Another Approach to Injury 
In 1999, Dr. Joe Hamill published a paper exploring the use of dynamical systems 
theory in studying lower extremity overuse injuries (42).  Since then, this approach has 
slowly been gaining traction in the running injury literature.  Instead of studying 
individual injury factors, the dynamical systems accounts for the interaction of multiple 
injury factors by studying the variability of a system on a macroscopic level (42,44).  A 
common quantitative method within this approach is called continuous relative phase, 
abbreviated CRP.  This method combines both spatial and temporal information into one 
measure of coordination that can be used to quantify the variability of the system being 
studied – in this case, a runner (42,44).   
 The concept of coordinative variability is central to the dynamical systems 
approach, and needs to be distinguished from end-point variability.  While end-point 
variability refers to variation in the end-goal of the motion (for example, hitting a bulls-
eye in darts), coordinative variability refers to the manner in which the joints and 
segments involved in the motion interact to control movement (for example, how the 
shoulder, elbow, wrist and hand interact to throw the dart) (44).  While most tasks 
demand low end-point variability, low coordinative variability has been implicated in 
overuse injury risk, as it may lead to repetitive loading of the same structures (42,44,69).  
This holds true for runners with PFPS, who appear to display lower CRP variability 
between the thigh and shank and between the shank and foot segment compared to 
healthy controls (42).  However, proximal coordinative variability has not been studied in 
running, which appears important given the previously discussed proximal risk factors. 
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Dissertation Aims 
While the dynamical systems approach adds to our understanding of PFPS 
etiology, its findings are hard to understand from a clinical perspective.  Thus, while it’s 
important to consider this approach, understanding individual risk factors for injury is 
still vitally important.  For PFPS, while many biomechanical, neural, and muscular 
factors have been identified, the relationship between many of these factors is unclear, 
which complicates intervention strategies for this injury.  In particular, while proximal 
muscle strengthening has become part of the standard of care for PFPS rehabilitation and 
has led to positive functional outcomes (1,10,26,30,32,45,57,74,84), proximal running 
kinematics do not appear to change as a result of a 6-8 week strengthening protocol 
(26,32,100,120,125).  No studies to date have investigated whether proximal muscle 
strength is related to the amplitude or timing of proximal muscle activation during 
running.  In addition, many risk factors for PFPS appear to sex-specific (119), which 
means that studying these relationships should consider sex as an important factor.   
Therefore, the overall aim of this project is to examine the relationships between 
hip muscle strength, hip muscle activation during running, and running kinematics at the 
knee, hip, pelvis, and trunk in both male and female runners.  To accomplish this overall 
aim, the project is divided into four main studies, each with a specific aim: 
Aim 1. Hip muscle strength and hip muscle activation during running have both 
been cited as potential risk factors for PFPS.  However, the relationship between these 
variables has not been studied.  Therefore, the first specific aim is to determine the 
relationship between maximum hip muscle strength and hip muscle activation 
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(amplitude, onset, offset, and duration) during running.  It was hypothesized that hip 
muscle strength and hip muscle activation will not be correlated. 
Aim 2. Excessive hip adduction and hip internal rotation appear to place females 
at higher risk for developing PFPS.  While some studies have looked at individual factors 
that may be correlated to hip adduction (117) and hip internal rotation (102,117), no 
study has attempted to look at multiple factors at the same time.  Therefore, using a 
multiple regression approach, the second specific aim of this project is to determine 
whether any demographic, clinical, anthropometric, hip muscle strength, or hip muscle 
activation during running are related to hip adduction and hip internal rotation during 
running in both males and females.  It was hypothesized that gluteus medius and gluteus 
maximus onset would be correlated with hip adduction excursion, and gluteus maximus 
onset would be correlated with hip internal rotation excursion in females only. 
Aim 3. Proximal muscle strengthening over a 6-8 week period does not appear to 
alter proximal kinematics in healthy or injured runners.  However, hip muscle activation 
during running may be related to hip kinematics.  Thus, the relationship between hip 
strength, hip muscle activation, and proximal kinematics during running is still very 
unclear.  It is important for clinicians to know how manipulating hip strength may change 
muscle activation and kinematics at the hip.  However, strengthening has to be done 
slowly over time, meaning subjects may adapt and other factors can affect the results.  
Decreasing strength, however, can be done rapidly by fatiguing or weakening the muscle 
group of interest.  Therefore, the third specific aim is to examine the effect of decreasing 
hip abduction strength on hip muscle activation (amplitude, onset, offset, duration) and 
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proximal running kinematics.  It was hypothesized that decreasing hip abduction strength 
would not affect hip muscle activation or proximal running kinematics. 
Aim 4. Low coordinative variability has been implicated in injury risk.  No study 
has looked at the effect of decreasing hip abduction strength on CRP variability at the 
hip.  Therefore, the fourth specific aim is to examine the effect of decreasing hip 
abduction strength on CRP variability at the hip and knee.  It was hypothesized that CRP 
variability would increase with decreased hip abduction strength. 
 
Flow of the Dissertation 
 This dissertation is structured in journal format and includes co-authored material 
written in preparation for publication in peer-reviewed journals.  Following this 
introduction in Chapter I, Chapters II-V are individual studies to address each specific 
aim.  Chapter II investigates the relationship between hip muscle strength and hip muscle 
activation during running and is co-authored by Drs. Li-Shan Chou and Brian Dalton.  
Chapter III then uses a multiple regression approach to investigate factors that may 
predict hip adduction and hip internal rotation during running and is co-authored by Drs. 
Li-Shan Chou, Brian Dalton, and Stan James.  Chapter IV details the fatigue protocol 
methodology, as well as the effect of decreasing hip abduction strength on hip abductor 
muscle activity and proximal kinematics during running, and is co-authored by Dr. Li-
Shan Chou.  Chapter V investigates the effect of decreased hip abduction strength on 
CRP variability at the hip and is co-authored by Dr. Li-Shan Chou.  Finally, Chapter VI 
provides a final discussion and conclusion, clinical implications, and future directions for 
research from the summative results of this dissertation. 
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CHAPTER II 
THE RELATIONSHIP BETWEEN HIP MUSCLE STRENGTH AND HIP MUSCLE 
ACTIVATION DURING RUNNING IN MALES AND FEMALES 
 
 This chapter contains co-authored material.  JJ Hannigan was responsible for the 
conceptual development, development of the protocol, data collection and analysis, and 
writing of the manuscript.  Dr. Li-Shan Chou contributed to the conceptual development 
and refinement of the protocol, and provided critiques and editing for the manuscript.  Dr. 
Brian Dalton provided technical advice for the EMG data collection and analysis.  
 
Introduction 
Weak hip muscle strength, particularly in the hip abductor muscles, appears to be 
a major risk factor for developing patellofemoral pain syndrome (PFPS) in females 
(11,23,52,71,93,101).  Hip and core strengthening programs have been shown to increase 
strength while decreasing pain and improving functional outcomes in runners with PFPS 
(1,10,26,30,32,45,57,74,84).  Such strengthening programs have thus become a 
cornerstone of PFPS treatment and rehabilitation. 
One limitation of these programs, however, is that they do not appear to change 
lower extremity kinematics during running  (26,32,100,120,125).  Certain kinematic 
patterns during running, particularly “excessive” peak hip adduction and peak hip internal 
rotation, appear to place female runners at a greater risk of developing PFPS (74,80–
82,101,115,119).  Thus, if these strengthening programs do not change kinematics, these 
kinematic risk factors of injury remain present after rehabilitation, placing the runner at a 
high likelihood of re-injury. 
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 Hip muscle activation during running may also play a role in the development of 
PFPS, possibly due to their relationship with hip kinematics.  A study by Willson et al. 
(2011) demonstrated that females with PFPS display delayed and shorter gluteus medius 
activation compared to healthy females, which was significantly correlated with hip 
adduction excursion (i.e., as onset time became more delayed, hip adduction excursion 
increased).  Excessive hip adduction excursion could lead to greater peak hip adduction, 
thus placing a runner at a higher risk of injury. 
The relationship between hip strength and hip kinematics during running is not 
clear.  While one study found significant correlations between isokinetic hip abduction 
strength and pelvic drop in a mixed-sex cohort (35) other studies have found no 
relationship between isometric hip abduction strength and hip adduction (4) or hip 
internal rotation (102) in females.  Another study found that isokinetic hip abduction 
strength was correlated with hip adduction range of motion, but not hip internal rotation 
range of motion in males (107). 
To help clarify this relationship, the dynamic activity of the hip muscles needs to 
be further studied in runners.  No study has investigated whether isometric measures of 
muscle strength (as typically measured in-clinic) have any relationship between hip 
muscle activation during running.  Knowing this relationship would help researchers and 
clinicians better understand the role of maximum muscle strength in PFPS injury risk. 
Sex appears to be an important consideration when investigating these 
relationships, due to the sex differences risk factors for PFPS (119) and the previously 
cited relationships between strength and kinematics.  Thus, the primary purpose of this 
study was to investigate the correlations between hip muscle strength and hip muscle 
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activity during running in males and females.  A secondary purpose was to investigate 
sex differences in hip strength and hip muscle activity to compare to previous studies and 
add to the body of literature in this area.  Based on this previous literature, it was 
hypothesized that hip muscle strength would not be related to any measure of hip muscle 
activity, but that females would display lower hip abduction and external rotation 
strength, and higher gluteus maximus amplitude compared to males. 
 
Methods 
Subjects 
 Prior to participation, all subjects signed an informed consent form approved by 
the University of Oregon (Appendix B).  To be included in the study, subjects needed to 
be between 18-45 years old (81,101), average running at least 20 miles per week over the 
past month (129), and report no major injuries for at least the previous 6 months (6,21).  
A major injury was consistent with the consensus definition by Yamato el al. (127) as 
pain that required a restriction or stoppage of running for at least 1 week or 3 training 
sessions, or that required treatment from a medical professional (127).  
Protocol and Equipment – Visit 1 
 Subjects visited the Motion Analysis Laboratory for two visits, separated by a 
minimum of 72 hours.  Tests were performed on separate days so that performing the 
muscle strength assessment did not affect muscle recruitment patterns during running.  
The maximum isometric muscle strength assessment was performed during visit 1.  Prior 
to performing the strength assessment, all subjects warmed up five minutes on the 
treadmill at their easy pace.  All isometric muscle strength tests were then performed for 
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both limbs on the Biodex System 3 Dynamometer (Biodex Medical Systems, Shirley 
NY). 
 For all tests, the greater trochanter was aligned with the rotational axis of the 
dynamometer.  Hip abduction strength was measured with the subject sidelying on a 
padded treatment table with the hip in 0-degrees of abduction, flexion, or rotation.  The 
resistance pad was placed 3 finger lengths proximal to the joint line of the knee and 
secured tightly to the thigh (Figure 1A).  Hip adduction strength was measured in the 
same position, except the hip was moved to 30º of abduction (Figure 1B). 
 
  
Figure 1. A) Hip abduction and B) hip adduction strength testing positions 
 
A 
B 
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Hip extension strength was measured with the subject prone on the treatment table 
with the hip in neutral and knee flexed to 90º.  The resistance pad was placed 3 finger 
lengths proximal to the popliteal fossa and secured tightly to the thigh (Figure 2A).  Hip 
flexion strength was measured with the subject supine on the treatment table with the hip 
flexed to 30º.  The resistance pad was placed 3 finger lengths proximal to the superior 
border of the patella and secured tightly to the thigh (Figure 2B). 
 
 
Hip internal and external rotation strength were both measured with the subject 
prone on the treatment table with the hip in neutral and the knee flexed to 90º.  The 
Figure 2. A) Hip extension and B) hip flexion strength testing positions 
 
A 
B 
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resistance pad was placed immediately proximal to the lateral malleolus and secured 
tightly to the distal shank (Figure 3). 
 
For each direction of movement, subjects pushed maximally three times for five 
seconds.  Consistent verbal encouragement was provided for each maximal effort.  For all 
tests except for hip internal and external rotation, these efforts were performed in a single 
set per limb with fifteen seconds in between efforts.  Hip internal and external rotation 
strengths were alternated in the same set, with fifteen seconds in between each five-
second effort.  Subjects had at least one minute of rest between each direction of 
movement as the subject and dynamometer were repositioned. 
Protocol and Equipment – Visit 2 
 During Visit 2, subjects began with a five-minute warmup at their easy pace on a 
treadmill.  Subjects were then outfitted with a vest attached to a 6-channel EMG 
backpack with adjustable gain (MA-300, Motion Lab Systems, Baton Rouge LA) (Figure 
4A).   
Figure 3. Hip internal rotation and external rotation strength testing positions 
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Prior to electrode placement, the skin was lightly abraded and cleaned with an 
alcohol pad over the site of electrode placement locations.  Six pre-amplified electrodes 
with 17mm inter-electrode distance (Figure 4B) and one ground electrode were then 
placed directly on the skin.  Conducting gel was placed between the skin and electrodes 
and several strips of white athletic tape secured the electrodes to the skin.  The active 
electrodes were placed on the tensor fascia latae (TFL), gluteus medius (GMED) and 
gluteus maximus (GMAX) bilaterally.  The TFL electrode was placed vertically on the 
TFL muscle belly, located just inferior and posterior to the anterior superior iliac spine.  
The gluteus medius electrode was placed vertically in between the iliac crest and greater 
trochanter, approximately one-third of this distance below the iliac crest.  The gluteus 
maximus electrode was placed on a line half the distance between the greater trochanter 
and the inferior lateral edge of the sacrum (116,117).  The ground electrode was placed 
on the right clavicle.  The positioning of electrodes can be seen in Figure 4C. 
 
 
 
 
 
 
 
 
 
A B C 
Figure 4. EMG Setup A) MA-300 backpack setup, B) MA-411 EMG pre-amplifier, C) 
Preamplified electrode placement on the TFL, GMED, and GMAX muscles bilaterally 
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The EMG pre-amplifier contained a band-pass filter from 15 to 3500 Hz and a gain 
of 20.  At the backpack, the signal was band-pass filtered from 20 to 500 Hz, and the gain 
was manually adjusted to 4000 unless this produced signal clipping during the MVIC.  
This signal was then fed to a desktop amplifier (gain = 2) via a coaxial connection cable 
which fed the analog signal through a 12-bit A/D board connected to the motion capture 
computer in the Motion Analysis Laboratory.  This signal was collected using Cortex 5 
motion capture software (Motion Analysis Corporation, Santa Rosa CA) sampling at 
1000 Hz.  
The signal to noise ratio was visually inspected as the subject performed standing 
hip abduction and hip extension.  If the signal to noise ratio was not acceptable, slight 
adjustments were made to the electrode placement and the signal to noise ratio was 
retested. 
Maximum voluntary isometric contractions (MVICs) were then performed on a 
padded treatment table.  For the gluteus maximus MVIC, the subject was positioned 
prone with the knee flexed to 90º (116,117).  Two stabilization straps were tightly 
attached just distal to the gluteal fold and just proximal to the popliteal fossa on one leg.  
A researcher also helped stabilize the subject by placing their hands on the thigh during 
the test.  Subjects were instructed to push up against the straps using their gluteal muscle 
with maximal force for five seconds.  This was repeated for the same leg after 45 seconds 
and was then repeated on the opposite leg. 
Based on pilot testing, MVICs for gluteus medius and TFL were performed with 
the subject sidelying and the hip in 0º of flexion and rotation, and 10º of abduction.  Two 
stabilization straps were attached just proximal to the knee and just proximal to the ankle 
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with tautness that would allow 10º of abduction.  Similar to GMAX MVIC testing, a 
researcher helped stabilize the subject’s leg during testing to avoid the subject rotating 
their body.  Subjects were instructed to push up against the straps using their hip abductor 
muscles with maximal force for five seconds.  This was repeated for the same leg after 45 
seconds and was then repeated on the opposite leg. 
 Subjects then ran continuous laps of approximately 40-meters in the Motion 
Analysis Laboratory at their easy run pace.  This pace was defined as the pace a subject 
could comfortably maintain for 30 minutes while maintaining a conversation.  Data were 
collected when the participants passed through a straight 10-meter region in the center of 
the capture volume. Participants were instructed not to alter their stride to hit three force 
plates (AMTI, Watertown, MA) located in series in this region. Subjects were given two 
laps to become accustomed to running in the lab before data were collected.  Subjects 
then completed 20 laps in the laboratory. 
Data Processing and Analysis 
 To quantify muscle strength, mean maximal torque for each strength parameter 
and limb was calculated by averaging the peak torque generated during the three efforts.  
This mean value was normalized by body mass for analysis. 
 Five running trials per limb per subject were selected for analysis (116,117).  
Only trials where the foot cleanly struck a force plate were selected.  Foot strike was 
defined as the first frame where the vertical ground reaction force exceeded 50 Newtons 
(N), and toe off was defined as the first frame where the vertical ground reaction force 
fell below 50 N.   
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All EMG data were processed and analyzed using a custom LabView program.  
EMG data were band-pass filtered from 20-450 Hz, root-mean-square (RMS) averaged 
and smoothed using a 50 ms sliding window.  To determine the MVIC for each muscle, 
both trials were processed.  For both MVIC attempts, a sliding 500 ms window calculated 
the mean amplitude of the highest signal portion of the MVIC trial.  The highest value 
between trials was determined the MVIC value for each muscle.  
Running trials were trimmed to 250 ms before foot strike and 250 ms after toe off, 
respectively, for analysis.  Due to variability in the data, no set threshold above baseline 
was determined feasible to consistently determine EMG onset.  Therefore, EMG onset 
and offset was defined by visual inspection by the same examiner, which has shown to be 
reliable (53).  EMG onset was defined as the first major vertical deflection of the EMG 
signal (53) during the 250 ms window before heel strike which remained above baseline 
for at least 25 ms (116,117).  EMG offset was defined as the last major vertical deflection 
of the EMG signal (53) which remained below baseline for at least 25 ms (116,117).   
EMG onset is represented numerically as the time in milliseconds before foot strike, 
while EMG offset is represented numerically as the time in milliseconds before toe-off 
(Figure 5).  EMG duration was calculated as the difference between the onset and offset 
times (Figure 5). 
EMG peak amplitude was calculated as the maximum EMG recording within the 
visually determined onset and offset times (Figure 5).  This maximum EMG value was 
normalized by the MVIC for that muscle.  All four EMG parameters were then averaged 
between the five trials for analysis.  In rare cases where the mean peak amplitude 
 22 
 
exceeded 200% MVIC, this data point was discarded for analysis, as it was assumed the 
subject was not able to perform a true MVIC for that muscle. 
Statistical Analysis 
All EMG parameters were compared between sexes using unpaired t-tests.  For all 
sex comparisons, the alpha-level was set to 0.05.  Pearson correlation coefficients 
determined the relationship between strength and EMG measures.  Due to the number of 
correlations performed, the alpha-level was lowered 0.01 to reduce the risk of committing 
a Type I error.  All statistics were calculated using SPSS version 23 (SPSS Inc., Chicago 
IL), except for effect sizes, which were calculated using G*Power 3.1 (G*Power, 
Düsseldorf, Germany). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Sample visual depiction of EMG variable calculations.  The green and red 
lines represent visually determined EMG onset and offset.  The actual onset and offset 
variables used in this analysis were calculated relative to foot strike and toe-off.  EMG 
duration was the time difference between visually determined EMG onset and offset.  
Peak amplitude was the maximum EMG signal between the EMG onset and offset. 
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Results 
 Thirty subjects, 15 males and 15 females, met the inclusion criteria and 
participated in the study.  Subject demographics can be seen in Table 1.  
Table 1.  Subject demographics for females and males. 
      Females      Males    p-value 
Age (years) 27.5 ± 5.8 26.3 ± 8.3 0.648 
Height (cm) 166.3 ± 4.3 177.8 ± 7.8 < 0.001* 
Weight (kg) 59.1 ± 6.0 72.0 ± 11.4 < 0.001* 
Weekly Mileage (miles) 27.7 ± 9.6 37.0 ± 15.8 0.061 
Running Experience (years) 13.4 ± 5.7 11.5 ± 6.5 0.404 
Running Speed (m/s) 3.0 ± 0.3 3.1 ± 0.4 0.300 
* Indicates a significant difference between sexes, p < .05. 
 
 Males displayed significantly greater hip flexion strength (p = .004), hip internal 
rotation strength (p = .025), and hip external rotation strength (p < .001) compared to 
females.  No differences were seen in hip abduction strength, hip adduction strength, or 
hip extension strength (Table 2). 
 Males displayed significantly earlier GMAX onset prior to foot strike (p < .001) 
and longer GMAX duration (p = .019) compared to females.  There was a trend towards 
males displaying greater GMAX peak amplitude (p = .061) compared to females (Table 
2). 
Combining males and females together, there were no significant correlations 
between any measure of muscle strength and EMG.  In males only, there were also no 
significant correlations between any measure of strength and EMG.  In females, there 
was a significant correlation between hip abduction strength and TFL onset (r = .494, p = 
.006).  No other correlations were significant (Tables 3 & 4). 
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Table 2.  Sex differences in strength and EMG. 
* Indicates a significant difference between sexes, p < .05. 
 
 
Table 3.  Pearson correlation coefficients between hip strength and EMG measures. 
 
 
 
 Females Males p-value Effect Size 
Strength (Nm/kg)     
     Hip Abduction 1.41 ± 0.26 1.51 ± 0.28 0.172 0.370 
     Hip Adduction 1.65 ± 0.34 1.82 ± 0.37  0.075 0.478 
     Hip Extension 1.20 ± 0.34 1.28 ± 0.33 0.360 0.239 
     Hip Flexion 1.04 ± 0.30 1.31 ± 0.38  0.004* 0.789 
     Hip Internal Rotation 0.36 ± 0.09 0.41 ± 0.08 0.025* 0.587 
     Hip External Rotation 0.30 ± 0.09 0.45 ± 0.10 < 0.001* 1.577 
EMG (Amplitude = % MVIC; Onset, Offset, Duration = ms)  
     TFL Amplitude 78.44 ± 40.03 97.06 ± 53.97 0.141 0.391 
     TFL Onset 44.35 ± 41.18 33.93 ± 30.97   0.281 0.286 
     TFL Offset 79.35 ± 20.79 76.76 ± 19.49 0.627 0.129 
     TFL Duration 214.58 ± 44.29 198.00 ± 34.75 0.118 0.417 
     GMED Amplitude 86.08 ± 30.42 82.97 ± 31.21   0.726 0.101 
     GMED Onset 25.47 ± 25.48 39.87 ± 47.44 0.150 0.378 
     GMED Offset 82.47 ± 24.91 73.67 ± 30.89 0.229 0.314 
     GMED Duration 196.03 ± 32.12 207.13 ± 46.09 0.284 0.279 
     GMAX Amplitude 84.08 ± 38.11 63.61 ± 38.12  0.061 0.537 
     GMAX Onset 24.17 ± 34.63 59.60 ± 30.62 < 0.001* 1.084 
     GMAX Offset 72.35 ± 23.76 72.43 ± 24.41  0.989 0.003 
     GMAX Duration 203.21 ± 40.71 228.00 ± 38.09  0.019* 0.629 
 Hip Extension Strength  Hip External Rotation Strength 
  Females Males   Females Males 
GMAX Amplitude -0.027 -0.260  -0.295 -0.107 
GMAX Onset 0.327 -0.082  0.013 -0.181 
GMAX Offset -0.010 0.285  -0.067 0.205 
GMAX Duration 0.200 -0.188  -0.026 -0.150 
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Table 4.  Pearson correlation coefficients between hip strength and EMG measures. 
* Indicates a significant correlation, p < .01. 
 
Discussion 
 The main purpose of this study was to investigate the correlations between 
measures of hip muscle strength and hip muscle activation during running.  With one 
exception, there were no significant correlations between muscle strength and muscle 
activation parameters in either males or females, which mostly supported our hypothesis. 
 There were no significant relationships between maximum hip muscle strength 
and peak EMG amplitude.  The three hip muscles we studied all displayed average peak 
amplitudes between 60 to 99% of MVIC during running in both males and females.  
These values are larger than may be expected, which could be due to the high degree of 
negative work, and thus eccentric muscle activity, noted for these muscles at the 
beginning of their activation prior to foot strike (65).  However, despite peak EMG 
activity nearing MVIC levels during running, the maximum torque-generating capacity of 
the abductor and extensor muscle groups was not related to peak EMG amplitudes.  This 
finding suggests that the relative amplitude of hip muscle activation for all three muscles 
is not dependent on the strength of the collective muscle groups they comprise.  Thus, it 
 Hip Abduction Strength  Hip Internal Rotation Strength 
  Females  Males      Females Males 
TFL Amplitude 0.022 -0.301  0.246 0.125 
TFL Onset 0.494* -0.142  0.329 0.017 
TFL Offset 0.029 0.062  -0.108 0.066 
TFL Duration 0.427 -0.178  0.252 -0.253 
GMED Amplitude 0.014 -0.418  0.311 -0.104 
GMED Onset 0.133 -0.094  0.034 -0.085 
GMED Offset -0.088 0.183  -0.026 0.159 
GMED Duration -0.115 -0.036  -0.022 -0.181 
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remains unclear what physiologic factors, if any, may modulate peak hip muscle EMG 
amplitudes during running.  
 One timing variable was related to maximum strength, as there was a significant, 
moderate, positive correlation between hip abduction strength and TFL onset time in 
females (r = 0.494, p = .006).  In other words, as hip abduction strength increased, the 
time between TFL onset and initial foot contact also increased.  While earlier muscle 
onset may help contribute to dynamic hip stability (117), this finding likely does not have 
significant implications on kinematics or injury rates, as the TFL appears to be a very 
minor contributor to hip stability during running (65). 
 We also saw a non-significant but trending, moderate, positive correlation 
between hip extension strength and gluteus maximus onset in females (r =0.327, p = 
.083).  While this relationship is non-significant, it is worth noting, as gluteus maximus 
onset has been negatively correlated to hip adduction and hip internal rotation excursion 
in females with PFPS (117).  Thus, increasing hip extension strength may be considered 
during rehabilitation for females with PFPS. 
All other timing variables were not correlated to any maximum muscle strength 
variables.  Hence, it does not appear that maximum muscle strength has much 
relationship with the timing of muscle activation prior to foot strike, or the duration of hip 
muscle activity during running.  The lack of relationship between hip abduction strength 
and gluteus medius onset and duration in females is particularly noteworthy, as lower hip 
abduction strength (11,23,52,71,93,101) and delayed gluteus medius activity (117) have 
been found in females with PFPS compared to controls.  In addition there is limited 
evidence that suggests hip abduction strength (46) and gluteus medius onset (117) are 
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related to hip adduction excursion during running.  However, the findings from this study 
suggest that these variables are not related, meaning that hip abduction strength and 
gluteus medius onset appear to unrelated, independent risk factors for injury.  
Males, on average, displayed significantly greater hip flexion, hip internal 
rotation, and hip external rotation strength compared to females.  The hip external 
rotation strength finding supported our hypothesis.  Greater hip flexion strength (95), hip 
internal rotation strength (95), and hip external rotation strength (63,95) in males 
compared to females has been found in other populations, but not exclusively runners.   
Many (35,54,63,95,104), but not all (46) studies agree that healthy females have 
weaker hip abductors than males.  This study agreed with the latter, as we did not see a 
significant difference between sexes, which did not support our hypothesis.  While 
methodological differences may explain why our result was different than most, some 
studies used the same testing position and protocol as we did.  The result from this study 
questions whether weaker hip abductor muscles can help explain the sex bias for 
developing PFPS, and indicates further research is needed. 
Females displayed delayed and shorter GMAX activation compared to males.  
Willson et al. (2012) also found this trend, but their results did not reach statistical 
significance (116).  Delayed gluteus maximus onset has been correlated to greater hip 
adduction and hip internal rotation excursion in females with PFPS (117).  Since 
excessive hip adduction and hip internal rotation are both risk factors for developing 
PFPS, this finding may help explain the female sex bias for developing PFPS. 
While our data just missed reaching statistical significance, we did see a trend 
towards females displaying greater gluteus maximus activation than males, which did 
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reach a moderate effect size (p = .06, ES = 0.537).  Willson et al. (116) also found this 
result, which did reach statistical significance.  While the significance of this finding is 
not entirely clear, Willson et al. hypothesized that relatively larger GMAX activation in 
females may lead to greater muscle fatigue and thus poorer dynamic control of the hip 
during prolonged running (116). 
Also similar to Willson et al., we did not see any differences between males and 
females in gluteus medius timing or peak amplitude, suggesting that gluteus medius 
activation patterns do not contribute to the sex bias for developing PFPS (117).  Gluteus 
medius timing differences during running have been cited between healthy and injured 
females, however, indicating that this parameter is still an important risk factor for injury 
(117). 
Despite using different EMG systems and data processing steps, most EMG data 
presented in this study are very similar to Willson et al. (116) for both males and females. 
Comparing GMAX parameters between studies, average activation duration was within 
12 ms for both males and females, while average peak amplitudes were within 4% of 
MVIC.  For GMED, average activation duration was within 7 ms for both females and 
males.  Average peak GMED amplitudes were slightly higher in Willson et al.’s study, 
with approximately the same mean difference between sexes.  This difference is likely 
due to slight differences in MVIC testing position.  While Willson et al. performed 
MVICs in 0º of abduction, we raised the hip to 10º of abduction, and saw average peak 
GMED amplitudes approximately 15% lower in both sexes.  Thus, we recommend 
placing the hip in 10º of abduction for future studies, as it may yield slightly higher 
MVICs. 
 29 
 
Overall, the degree of agreement in data between studies shows that our EMG 
measures are valid.  Furthermore, similarities in EMG duration for both GMAX and 
GMED indicate that using visual inspection to determine onset and offset times is a 
reliable method in running studies. 
 There are a few limitations in this study.  Surface EMG measures have several 
inherent limitations, such as muscle cross talk, movement artifact, and electrode 
placement errors, which can negatively affect the quality of EMG data.  Foot strike 
patterns (i.e., rearfoot versus forefoot) were not controlled in this study.  While foot strike 
pattern may affect distal muscle activation patterns (27,128), the effect on proximal 
muscle activation is unclear.  Similarly, the type of running shoe was not controlled in 
this study, although no subjects wore minimalist or maximalist footwear.  Finally, all 
subjects ran at the same relative effort, but not the same absolute pace.  This was because 
we wanted to assess muscle activation patterns at a runner’s easy pace, and assigning a 
specific pace would mean some runners may be running much faster or slower than 
normal.  We did perform a post-hoc correlation between running speed and all EMG 
variables, and did not find a correlation between speed and onset, amplitude, or duration.  
There were also no differences in average running speed between males and females, so 
we do not believe that running speed affected any of the sex difference results. 
In conclusion, hip muscle strength and hip muscle activity during running do not 
appear to be strongly correlated in healthy male or female runners.  Differences in hip 
muscle strength and hip muscle activity between sexes, however, may have injury 
implications related to the sex bias for developing PFPS. 
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Bridge 
 Chapter II explored the relationship between hip muscle strength and hip muscle 
activation during running, which found these factors to be mostly unrelated.  Chapter III 
uses these factors, along with clinical and anthropometric measurements, in a multiple 
regression model looking at predictors of hip adduction and hip internal rotation during 
running. 
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CHAPTER III 
PREDICTORS OF HIP ADDUCTION AND HIP INTERNAL ROTATION DURING 
RUNNING 
 
This chapter contains co-authored material.  JJ Hannigan was responsible for the 
conceptual development, development of the protocol, data collection and analysis, and 
writing of the manuscript.  Dr. Li-Shan Chou contributed to the conceptual development 
and refinement of the protocol, and provided critiques and editing for the manuscript.  Dr. 
Brian Dalton provided technical advice for the EMG data collection and analysis.  Dr. 
Stan James contributed to the development of the clinical examination. 
 
Introduction 
 Current evidence suggests that females with patellofemoral pain syndrome 
(PFPS) run with greater peak hip adduction (74,80–82,115,119) and peak hip internal 
rotation (81,82,101) compared to healthy females.  These biomechanical patterns are 
thought to decrease lateral patellofemoral contact area, which increases lateral 
patellofemoral contact stress (8,36).  Over time, this increased stress may cause tissue 
degradation in the subchondral bone, infrapatellar fat pad, peripatellar synovium, 
retinaculum, or patellar ligaments, initiating a pain signal from mechanoreceptors 
(19,36).   
 While hip and core strengthening programs have yielded positive functional 
outcomes during PFPS rehabilitation (1,10,26,30,32,45,57,74,84), these programs do not 
appear to decrease hip adduction or hip internal rotation during running 
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(26,32,100,120,125).  Thus, it appears that any reduction in knee pain stemming from 
these strengthening programs is not due to changes in hip or pelvis kinematics.  This is 
problematic – if the biomechanical risk factors for injury are still present, this likely 
places the runners at a high risk of re-injury. 
 Gait retraining (5,51,72,74,79,118,121) and cadence modification (40,47,64) have 
been successful at altering hip kinematics during running.  While these methods appear 
promising in altering running gait mechanics, factors outside of motor learning that may 
affect hip kinematics during running are still poorly understood, especially since the 
relationship between hip strength and hip kinematics appears tenuous (46).  No study to 
date has investigated factors related to hip adduction during running.  Factors affecting 
hip internal rotation during running have been marginally explored, as Souza et al. (2009) 
found hip extension endurance as a significant predictor of hip internal rotation (102).  
However, the number of predictor variables entered into their model was limited. 
 Risk factors related to demographics (59,106), anthropometry (24,59,60,122,123), 
static range of motion (59,74), hip strength (11,16,23,52,71,78,93,101,111), and hip 
muscle activation (74,117) have all been linked to knee injuries.  Knowing which of these 
factors may be related hip adduction and hip internal rotation motion during running is 
important, especially for clinicians searching for targeted areas of intervention during 
rehabilitation.  Therefore, the primary purpose of this study is to investigate factors 
related to hip adduction and hip internal rotation during running.  It was hypothesized 
that sex and measures of hip muscle activation would be predictive factors for both 
biomechanical variables.  Because of the hypothesized importance of sex in both models, 
a secondary purpose of the study was to investigate sex differences in the all variables 
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analyzed.  Because sex differences in hip strength and hip EMG were already presented 
in Chapter II, sex differences in the clinical and kinematic variables will be presented 
here.  It was hypothesized that females would display significantly greater static range of 
motion at the hip and greater hip adduction and internal rotation excursion during running 
compared to males. 
 
Methods 
Subjects 
 To be included in the study, subjects needed to be between 18-45 years old 
(81,101), average running at least 20 miles per week (129), and report no major injuries 
for at least the previous 6 months (6,21).  A major injury was consistent with the 
consensus definition by Yamato el al. (2015) as pain that required a restriction or 
stoppage of running for at least 1 week or 3 consecutive days, or that required treatment 
from a medical professional (127).  Prior to participation, all subjects signed an informed 
consent form approved by the University of Oregon (Appendix B).   
Protocol and Equipment – Visit 1 
 Data collection was divided into two days separated by a minimum of 72 hours so 
that the muscle strength testing did not affect running kinematics.  During day one, 
anthropometric, clinical, and strength data were collected after a five-minute warmup run.  
The clinical examination included measurements of range of motion, flexibility, and 
static posture, which are described in Table 5.  All angle measurements were made with a 
goniometer by the same trained clinician, with the exception of standing Q-angle, which 
was calculated based on marker positions during the static motion capture trial.   
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Table 5. Description of clinical exam measures 
Clinical Measure Description 
Standing Leg Varus to Floor (º) 
Angle of the shank relative to vertical when standing barefoot with 
legs shoulder width apart 
Standing Q-angle (º) 
Angle between a line formed from the tibial tubercle to the patella 
and a line formed from the patella to the ASIS when standing with 
the legs shoulder width apart 
Standing Arch Type 
Clinician’s assessment of standing arch type, ranging from 1 (very 
flat feet) to 5 (very high arch)  
Arch Height Index 
Truncated foot length (heel to 1st MPJ) divided by height of the 
dorsal aspect of the foot measured at ½ of total foot length 
Stork Test 
Clinician’s assessment of the movement (normal or restricted) of 
the PSIS relative to the sacrum as the subject balances on one leg 
and raises the other leg to 90º of hip flexion and knee flexion 
Static Ankle Dorsiflexion (º) 
Angle formed between the shank and foot during active ankle 
dorsiflexion with the knee extended (ADf) and flexed (ADe) 
Static Ankle Plantarflexion (º) 
Angle formed between the shank and foot during active ankle 
plantarflexion with the knee flexed 
Static Subtalar Inversion (º) 
Angle formed between the shank and foot during active ankle 
inversion in a prone position 
Static Subtalar Eversion (º) 
Angle formed between the shank and foot during active ankle 
eversion in a prone position 
Static 1st MPJ Dorsiflexion (º) 
Angle formed between the great toe and the foot during active great 
toe dorsiflexion 
Static Hip Internal Rotation (º) 
Angle formed between the shank and horizontal as the thigh is 
internally rotated in a prone position and knee flexed to 90º 
Static Hip External Rotation (º) 
Angle formed between the shank and horizontal as the thigh is 
externally rotated in a prone position and knee flexed to 90º 
Quadriceps Flexibility (º) 
Angle formed between thigh and shank during maximum passive 
knee flexion in a prone position 
Hamstring Flexibility (º) 
Angle formed between the shank and vertical as the knee is 
passively flexed in a prone position with the hip flexed to 90º 
Thomas Test (º) 
Angle formed between the thigh and horizontal as the subject leans 
their trunk prone on a treatment table and lets their thigh  
Ober’s Test 
Does the thigh fall below horizontal (negative) or stay above 
horizontal (positive) as the leg is extended and knee slightly bent 
while lying in a sidelying position 
Seated Tibial Torsion (º) 
Angle formed between the thigh and foot as the subject sits with 
legs off a table 
 
 All isometric muscle strength tests were then performed for both limbs on the 
Biodex System 3 Dynamometer (Biodex Medical Systems, Shirley NY).  For each test, 
the greater trochanter was aligned with the rotational axis of the dynamometer.  Strength 
testing positions can be seen in Chapter II (Figures 1-3).  For each direction of 
movement, subjects pushed maximally three times for five seconds.  Consistent verbal 
encouragement was provided for each maximal effort.  For all tests except for hip internal 
and external rotation, these efforts were performed in a single set per limb with fifteen 
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seconds in between efforts.  Hip internal and external rotation strengths were alternated in 
the same set, with fifteen seconds in between each five-second effort.  Subjects had at 
least one minute of rest between each direction of movement as the subject and 
dynamometer were repositioned. 
Protocol and Equipment – Visit 2 
 Subjects warmed up at their easy pace on a treadmill for five minutes and were 
then outfitted with a vest attached to a 6-channel EMG backpack with adjustable gain 
(MA-300, Motion Lab Systems, Baton Rouge LA) (Figure 4A).   
Prior to electrode placement, the skin was lightly abraded and cleaned with an 
alcohol pad over the site of electrode placement locations.  Six pre-amplified electrodes 
(Figure 4B) with 17mm inter-electrode distance and one ground electrode were then 
placed directly on the skin.  Conducting gel was placed between the skin and electrodes 
and several strips of white athletic tape secured the electrodes to the skin.  The active 
electrodes were placed on the tensor fascia latae (TFL), gluteus medius (GMED) and 
gluteus maximus (GMAX) bilaterally.  The positioning of electrodes can be seen in 
Figure 4C. 
The EMG pre-amplifier contained a band-pass filter from 15 to 3500 Hz and a gain 
of 20.  At the backpack, the signal was band-pass filtered from 20 to 500 Hz, and the gain 
was manually adjusted to 4000 unless this produced signal clipping during the MVIC.  
This signal was then fed to a desktop amplifier (gain = 2) via a coaxial connection cable 
which fed the analog signal through a 12-bit A/D board connected to the motion capture 
computer in the Motion Analysis Laboratory.  This signal was collected at 1000 Hz using 
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Cortex 5 motion capture software (Motion Analysis Corporation, Santa Rosa CA) so that 
EMG and motion capture data would be synchronized.  
The signal to noise ratio was visually inspected as the subject performed standing 
hip abduction and hip extension.  If the signal to noise ratio was not acceptable, slight 
adjustments were made to the electrode placement and the signal to noise ratio was 
retested. 
Maximum voluntary isometric contractions (MVICs) were then performed on a 
padded treatment table.  For the gluteus maximus MVIC, the subject was positioned 
prone with the knee flexed to 90º (116,117).  Two stabilization straps were tightly 
attached just distal to the gluteal fold and just proximal to the popliteal fossa on one leg.  
A researcher also helped stabilize the subject by placing their hands on the thigh during 
the test.  Subjects were instructed to push up against the straps using their gluteal muscle 
with maximal force for five seconds.  This was repeated for the same leg after 45 seconds 
and was then repeated on the opposite leg. 
Based on pilot testing, MVICs for gluteus medius and TFL were performed with 
the subject sidelying and the hip in 0º of flexion and rotation, and 10º of abduction.  Two 
stabilization straps were attached just proximal to the knee and just proximal to the ankle 
with tautness that would allow 10º of abduction.  Similar to GMAX MVIC testing, a 
researcher helped stabilize their leg during testing to avoid the subject rotating their body.  
Subjects were instructed to push up against the straps using their hip abductor muscles 
with maximal force for five seconds.  This was repeated for the same leg after 45 seconds 
and was then repeated on the opposite leg. 
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Subjects were then outfitted with 39 reflective markers (6,41).  The pelvis was 
defined by two markers on the anterior superior iliac spines, and one at the midpoint 
between the posterior superior iliac spines.  The femur was defined by two markers at the 
medial and lateral femoral epicondyles, and one marker mid-thigh in line with the lateral 
epicondyle and greater trochanter.  The hip joint center was defined by measurements of 
ASIS breadth (112). 
Subjects then ran continuous laps of approximately 40-meters in the Motion 
Analysis Laboratory at their easy run pace while whole body kinematics were collected 
with a 10-camera motion capture system (Motion Analysis Corp., Santa Rosa CA) 
sampling at 200 Hz.  This pace was defined as the pace a subject could comfortably 
maintain for 30 minutes while maintaining a conversation.  Participants were instructed 
not to alter their stride to hit three force plates (AMTI, Watertown, MA) located in series 
in this region.  Subjects were given two laps to become accustomed to running in the lab 
before data were collected.  Subjects then completed 20 laps in the laboratory.  Data were 
collected when the participants passed through a straight 10-meter region in the center of 
the capture volume.  
Data Processing and Analysis 
 To quantify muscle strength, mean maximal torque for each strength parameter 
and limb was calculated by averaging the peak torque generated during the three efforts.  
This mean value was normalized by body mass for analysis. 
 Five running trials per limb per subject were selected for analysis (116,117).  
Only trials where the foot cleanly struck a force plate were selected.  Foot strike was 
defined as the first frame where the vertical ground reaction force exceeded 50 Newtons 
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(N), and toe off was defined as the first frame where the vertical ground reaction force 
fell below 50 N (14).  Marker trajectories were identified using Cortex 5.0 motion capture 
software (Motion Analysis Corp., Santa Rosa CA) and were smoothed using a low-pass, 
fourth-order, zero-lag Butterworth filter with an 8 Hz cutoff.  A custom LabView 
program (National Instruments, Austin TX) calculated hip angles during stance phase 
using a YXZ cardan angle rotation sequence.  Angular excursion of the hip was defined 
as the difference between the angle at initial contact and the peak angle during stance 
phase (4).  Angular excursion was selected as the biomechanical variable in this study 
because it is less sensitive to between-day variability in marker placement compared to 
peak angles (29), represents the time period during stance phase where the hip muscles 
must act to decelerate the center of mass and control excessive hip motion (102), and has 
been used in several similar studies (4,35,107).  
All EMG data were processed and analyzed using a custom LabView program.  
EMG data were band-pass filtered from 20-450 Hz, root-mean-square (RMS) averaged 
and smoothed using a 50 ms sliding window.  To determine the MVIC for each muscle, 
both trials were processed.  For both MVIC attempts, a sliding 500 ms window calculated 
the mean amplitude of the highest signal portion of the MVIC trial.  The highest value 
between trials was determined the MVIC value for each muscle.  
Running trials were trimmed to 250 ms before foot strike and 250 ms after toe off, 
respectively, for analysis.  Due to variability in the data, no set threshold above baseline 
was determined feasible to determine EMG onset.  Therefore, EMG onset and offset was 
defined by visual inspection, which has shown to be reliable (53).  EMG onset was 
defined as the first major vertical deflection of the EMG signal (53) during the 250 ms 
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window before heel strike which remained above baseline for at least 25 ms (116,117).  
EMG offset was defined as the last major vertical deflection of the EMG signal (53) 
which remained below baseline for at least 25 ms (116,117).   EMG onset is represented 
numerically as the time in milliseconds before foot strike, while EMG offset is 
represented numerically as the time in milliseconds before toe-off (Figure 5).  EMG 
duration was calculated as the difference between the onset and offset times (Figure 5). 
EMG peak amplitude was calculated as the maximum EMG recording within the 
visually determined onset and offset times (Figure 5).  This maximum EMG value was 
normalized by the MVIC for that muscle.  All four EMG parameters were then averaged 
between the five trials for analysis.  In rare cases where the mean peak amplitude 
exceeded 200% MVIC, this data point was discarded for analysis, as it was assumed the 
subject was not able to perform a true MVIC for that muscle. 
Statistical Analysis 
All demographic, anthropometric, clinical, strength, and EMG variables served as 
potential predictor variables in the multiple regression models.  These variables were 
checked for assumptions of linearity, homoscedasticity, normality, and multicollinearity 
to assess whether the assumptions for performing a multiple regression analysis were 
violated.  Linearity and homoscedasticity were checked by visually inspecting the 
scatterplots of the studentized residuals against the unstandardized predicted values both 
collectively and for each predictor variable.  Multicollinearity was checked by assessing 
the variance inflation factors (VIFs). 
Due to high multicollinearity between variables, a principal component analysis 
(PCA) was run on the predictor variables (except for EMG measures, due to the number 
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of missing data points).  This was done in order to assess which variables were highly 
correlated and could be grouped into the same principal components.  Linearity between 
variables (r > 0.3) was checked, and any variable that was not correlated to another 
variable above this threshold was not included in the PCA.  Sampling adequacy was 
checked using Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy (KMO > 0.5) 
and Bartlett’s Test of Sphericity before principle components were calculated. 
To assess multicollinearity between EMG variables, bivariate correlations were 
calculated between variables, with a threshold of r > 0.8 indicating significant collinearity 
between variables. 
Bivariate correlations (Pearson’s correlation coefficients) were then calculated 
between all predictor variables and both hip adduction excursion and hip internal rotation 
excursion.  Bivariate correlations between the predictor and kinematic variables were 
assessed, with predictor variables of significance level p < .10 selected for inclusion in a 
stepwise multiple regression for each kinematic variable.  If two or more variables within 
the same principle component fit this criterion, only one was selected for inclusion in the 
stepwise regression.  Entry and exit criteria for the stepwise regression were set at p < .05 
and p > .10, respectively.  After performing both stepwise regressions, all assumptions of 
regression were rechecked. 
Sex differences in clinical and kinematic measures were assessed using unpaired t-
tests with an alpha-level of .05.  All statistics were calculated using SPSS version 23 
(SPSS Inc., Chicago IL), except for effect sizes, which were calculated using G*Power 
3.1 (G*Power, Düsseldorf, Germany). 
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Results 
Thirty subjects (15 males and 15 females) met the inclusion criteria and were 
included in this study.  Subject demographics can be seen in Chapter II (Table 1). 
 All regression assumptions of linearity, homoscedasticity, and normality were 
tenable.  However, numerous variables violated the assumption of multicollinearity, with 
many VIF values far exceeding 10.  Thus, a principal component analysis was performed 
on all predictor variables except measures of EMG.  EMG was excluded because the 
number of missing EMG data points exceeded the threshold to include in the PCA.  In 
total, all four TFL parameters were not included for 1 male subject, GMED amplitude 
was not included for 4 subjects (3 male, 1 female), and GMAX amplitude was not 
included for 4 subjects (2 male, 2 female) due to poor data quality.   
Subtalar inversion was removed from the PCA because it was not correlated with 
any other variable at the r > .30 level.  The KMO measure of sampling adequacy was 
0.502, which is considered just above the minimum threshold of 0.50 for performing a 
PCA.  Bartlett’s test of sphericity was statistically significant (p < .001), indicating that 
our data was suitable for PCA. 
 The first 6 principle components are listed in Table 6.  All measures of hip 
strength were contained in PC 1.  Descriptive variables of sex, height, and weight 
composed PC 2, along with hamstring flexibility.  PC 3 contained measures at the thigh, 
along with 1
st
 MPJ dorsiflexion.  PC 4 contained static ankle range of motion measures.  
Age and running history composed PC 5, and leg varus and tibial torsion made up PC 6. 
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  Table 6. Principal components and their percent of variance explained 
PC 
Percent of 
Variance 
Variables 
PC 1 16.7% 
Hip Abduction Strength, Hip Adductor Strength, Hip 
Extension Strength, Hip Flexion Strength, Hip External 
Rotation Strength, Hip Internal Rotation Strength 
PC 2 13.9% Sex, Height, Weight, Hamstring Flexibility 
PC 3 7.9% 
Static Hip Internal Rotation, Quadriceps Flexibility, Standing 
Q-Angle, Static 1
st
 MPJ Dorsiflexion 
PC 4 7.8% 
Static Ankle Dorsiflexion (knee flexed), Static Ankle 
Dorsiflexion (knee extended), Static Ankle Eversion 
PC 5 6.2% Age, Running History 
PC 6 5.8% Leg Varus, Tibial Torsion 
 
 For all three EMG measures, onset and duration were significantly correlated at r 
> 0.8 and were thus considered multicollinear (TFL onset and TFL duration: r = .870; 
GMED onset and GMED duration: r = 0.830; GMAX onset and GMAX duration: r = 
0.821).  
Sex, height, weight, running speed, TFL duration, GMAX amplitude, arch type, 
static subtalar inversion, quadriceps flexibility, hamstring flexibility, and Ober’s test were 
correlated with hip adduction excursion at p < 0.10.  Height and weight were excluded in 
favor of sex due to their collective presence in PC 2.  While hamstring flexibility was 
also included in PC 2, it was allowed into the stepwise regression as we determined its 
presence in this PC was likely due to the large sex difference in this variable (Table 11).  
The stepwise multiple regression model indicated that sex, running speed, GMAX 
amplitude, and subtalar inversion were all significant predictors of hip adduction 
excursion (r = 0.633, r
2 
= 0.401) (Table 7-8). The assumption of multicollinearity was 
tenable in this final model (Table 8).   
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 Table 7. Final variables added into stepwise hip adduction excursion regression model 
Variable 
Added 
r r
2 
r
2 
change F change Sig F change 
Subtalar 
Inversion 
0.365 0.133 0.133 7.219 0.010* 
GMAX 
Amplitude 
0.500 0.250 0.117 7.181 0.010* 
Speed 0.575 0.330 0.080 5.365 0.025* 
Sex 0.633 0.401 0.071 5.192 0.028* 
*Indicates significant F change, p < .05 
 
Table 8. Results of final regression model for hip adduction excursion 
Variable  B St. Error
 
p-value VIF 
(Constant) -10.55 3.262 0.002*  
Subtalar 
Inversion 
0.152 0.050 0.004* 1.007 
GMAX 
Amplitude 
0.015 0.007 0.048* 1.087 
Speed 2.602 0.947 0.009* 1.035 
Sex 1.278 0.561 0.028* 1.104 
*Indicates significance in the final model, p < .05 
 
Sex, height, weight, TFL offset, GMED onset, GMAX amplitude, GMAX offset, 
and external rotation strength were correlated with hip internal rotation excursion at p < 
0.10.  Height and weight were excluded in favor of sex due to their collective presence in 
PC 2.  The stepwise multiple regression model indicated that only sex was a significant 
predictor of hip internal rotation excursion (r = 0.351, r
2 
= 0.123) (Tables 9-10).  The 
assumption of multicollinearity was tenable in this final model (Table 10). 
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Table 9. Final variables added into stepwise hip internal rotation excursion regression 
model 
Variable 
Added 
r r
2 
r
2 
change F change Sig F change 
Sex 0.351 0.123 0.123 6.609 0.013 
*Indicates significant F change, p < .05 
 
 
Table 10. Results of final regression model for hip adduction excursion regression 
model. 
Variable  B St. Error
 
p-value VIF 
(Constant) 2.811 1.512 0.069  
Sex 2.460 0.957 0.013* 1.000 
*Indicates significance in final model, p < .05 
 
Sex differences in kinematic and clinical variables can be seen in Table 11.  
Females demonstrated greater hip adduction excursion and greater hip internal rotation 
excursion compared to males, p < .05.  Females also demonstrated greater static ankle 
plantarflexion, static hip internal rotation, and hamstring flexibility, and less tibial torsion 
compared to males, p < .05. 
 
Discussion 
 The main purpose of this study was to investigate significant predictors of hip 
adduction and hip internal rotation excursion during running.  Stepwise multiple 
regression models indicated that sex, running speed, GMAX amplitude, and static ankle 
inversion range of motion were significant predictors of hip adduction excursion, and 
only sex was a significant predictor of hip internal rotation excursion.  These findings 
partially supported our hypothesis. 
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Table 11. Sex differences in kinematic and clinical variables 
*Indicates a significant difference between sexes, p < .05 
 
 Being female was a significant predictor of hip adduction excursion during 
running (Table 7), and females displayed significantly greater hip adduction excursion 
compared to males (Table 11).  This result is not surprising, as previous studies indicated 
that healthy females run with greater hip adduction, on average, compared to males (31).  
While some authors have hypothesized this may be due to sex differences in hip and 
pelvis anatomy (31), no clinical or anthropometric variables at the hip, including standing 
Q-angle, were significant predictors of hip adduction in our model.  It is certainly 
possible that structural variables, such as femoral anteversion or the ratio between pelvic 
    Females Males p-value Effect Size 
Kinematic Variables     
   Hip Add Excursion 4.60 ± 1.84 3.30 ± 3.26 0.027* 0.491 
   Hip IR Excursion 7.73 ± 3.41 5.27 ± 3.26  0.006* 0.737 
Clinical Variables     
   Leg Varus 2.57 ± 3.55 2.20 ± 3.19 0.675 0.110 
   Ankle Dorsiflexion (ext) 5.03 ± 3.08 4.27 ± 2.74  0.313 0.261 
   Ankle Dorsiflexion (flex) 11.93 ± 3.46 10.77 ± 5.13 0.306 0.265 
   Ankle Plantarflexion 62.30 ± 8.09 54.13 ± 10.0 0.001* 0.898 
   Subtalar Inversion 23.00 ± 5.88 23.47 ± 4.93 0.740 0.087 
   Subtalar Eversion 9.46 ± 3.38 10.13 ± 5.13 0.555 0.154 
   1
st
 MPJ Dorsiflexion 45.30 ± 11.3 42.03 ± 15.4 0.353 0.242 
   Prone Hip IR 39.70 ± 9.58 34.23 ± 9.39 0.030* 0.577 
   Prone Hip ER 35.33 ± 8.86 33.63 ± 7.52 0.426 0.207 
   Quadriceps Flexibility 139.90 ± 9.80 139.20 ± 12.7 0.812 0.062 
   Hamstrings Flexibility 20.57 ± 10.5 33.57 ± 9.29 < 0.001* 1.311 
   Thomas Test 9.53 ± 9.21 9.67 ± 9.24 0.956 0.015 
   Tibial Torsion 4.53 ± 4.42 7.63 ± 4.69 0.011* 0.680 
   Arch Height 3.01 ± 0.24 3.02 ± 0.38 0.884 0.031 
   Standing Q-Angle 15.85 ± 7.02 17.77 ± 6.43 0.276 0.285 
 46 
 
width and femur length (102), could be significant predictors, but were not included in 
our analysis. 
In the final model for hip adduction, a one unit increase in GMAX amplitude was 
significantly associated with a 0.15 unit increase in hip adduction (Table 8).  This finding 
may indicate that runners with excessive hip adduction activate gluteus maximus at a 
higher percent of the maximum in an attempt to control frontal plane hip motion.  This 
could potentially indicate the GMAX amplitude during running is less of a “predictor” 
and more of a “result” of greater hip adduction excursion.  Though controlling frontal 
plane motion is not the primary function of gluteus maximus, some evidence suggests 
that the superior portion of the gluteus maximus does contribute to frontal plane torque at 
the hip (98,99).   
GMAX amplitude’s inclusion in the model is interesting given the trend towards 
greater gluteus maximus activation in females from Chapter II (Table 2), which has also 
been cited in previous literature (116).  Based on the combined results of these studies, 
female sex, gluteus maximus activation, and hip adduction excursion all appear to 
related, which is likely significant given that excessive hip adduction is a potential 
biomechanical risk factor for PFPS in females. 
A one unit increase in static subtalar inversion range of motion was significantly 
associated with a 0.152 unit increase in hip adduction excursion (Table 8).  Due to the 
lack of sex difference in this variable, this variable’s inclusion in the final model appears 
to be independent of sex.  This finding is difficult to explain, as during running the hip 
adducts for approximately the first 50% of stance phase, which coincides with ankle 
eversion, not inversion.  One hypothesis is that greater static ankle inversion range of 
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motion may allow runners to land in a more inverted position, giving them more total 
available eversion range of motion at the ankle during the first 50% of stance phase.  
Thus, greater available eversion range of motion could allow greater hip adduction 
excursion during running, given that these movements are likely coupled during the first 
half of stance phase (20).  The relationship between these variables certainly warrants 
further investigation. 
A one unit increase in running speed was significantly associated with a 2.602 
unit increase in hip adduction excursion (Table 8).  This was also not surprising given 
that many joint excursions increase with as speed increases (92).  This finding is 
important, as it indicates that regardless of sex, faster running is associated with an 
increase in hip adduction excursion, which may have negative consequences related to 
patellofemoral contact pressure (50).  Thus, this finding gives runners more reason to 
exercise caution when incorporating speed work into their training program. 
Gluteus medius amplitude and timing parameters were not included in the model 
for hip adduction excursion, which disagrees from the findings of Willson et al. (117), 
although Willson’s study looked at correlations in females with PFPS.  Gluteus medius is 
thought to be a major contributor to frontal plane hip stability during running (91), but 
gluteus maximus amplitude appeared to be a bigger predictor of hip adduction excursion 
during running.  More research is needed to explain this finding. 
 The only significant predictor variable in the hip internal rotation model was sex 
(Table 9), and females were found to run with greater hip internal rotation excursion 
compared to males (Table 11).  This finding partially supports our hypothesis and agrees 
with previous literature (31,46).  Based on the results of Souza et al. (2009), femoral 
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structure, while possibly related to PFPS incidence, does not appear to be related to hip 
internal rotation motion during running in females (102).  The results from our study also 
did not find any structural or clinical variables related to hip internal rotation excursion in 
our final model.  Using a bivariate approach, Willson et al. (2011) found that gluteus 
maximus onset was significantly correlated with hip internal rotation excursion (117).  
However, the results of our study did not find a significant relationship between gluteus 
maximus onset and hip internal rotation excursion, which disagrees with the results from 
Willson et al. (117).  It is possible that this difference between studies could be due to 
differences in calculating EMG onset, as we used visual inspection, while Willson et al. 
used a five standard deviation threshold above resting baseline. 
Females demonstrated greater static ankle plantarflexion, static hip internal 
rotation, and hamstring flexibility compared to males, which partially supported our 
hypothesis.  Greater static hip internal rotation may be due to structural differences at the 
pelvis and femur between sexes (70,102).  The differences in hamstring flexibility also 
agree with previous literature (113,114).  Females demonstrating greater static ankle 
plantarflexion range of motion appears to be a novel finding, but likely is not related to 
injury risk.  The greater amount of external tibial torsion found in males is also 
interesting, as excessive shank internal rotation may be a risk factor for PFPS (81).  
Whether tibial torsion and shank rotation during running are related, however, is 
unknown. 
While approximately 40% of the variance in hip adduction was explained by the 
variables in this study, only around 12% of the variance in hip internal rotation was 
explained.  The relatively low amount of variance explained in both models likely 
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suggests that dynamic control of the hip during running is a complex neurophysiological 
and biomechanical process that may be very runner-specific.  Hip muscle strength had 
been hypothesized as a significant factor related to hip and pelvis motion in runners 
(35,46,48,107).  However, strength was not a significantly correlated to joint excursions 
in either model.  This finding may help explain why hip strengthening during PFPS 
rehabilitation could not significantly alter hip kinematics during running  
(26,32,100,120,125). 
Every possible variable related to hip joint excursion during running could not be 
included in this study.  While running shoes were not standardized, the type of running 
shoe worn was not entered into the regression equation, which may limit the results.  
Further analyses could explore whether more variance is explained by using a more 
homogenous subgroup of runners (example: forefoot versus rearfoot strikers, or a tighter 
inclusion age range).  In addition, other biomechanical variables during running, both 
distal and proximal to the hip, were not included in this analysis.  Our sample size was 
also relatively low, just above the minimum cutoff to perform a PCA.  More subjects may 
be needed to increase the power of our regression model. 
In conclusion, sex, running speed, gluteus maximus activation, and static ankle 
inversion range of motion were significant predictors of hip adduction excursion, and sex 
was a significant predictor of hip internal rotation excursion.  While the relatively low 
amount of variance explained in both models suggests that dynamic control may be a 
complex process, the results will hopefully provide some insight into factors related to 
two major biomechanical risk factors for injury. 
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Bridge 
 Chapter III investigated variables that may be predictive of hip adduction and hip 
internal rotation excursion during running.  Hip muscle strength had previously been 
hypothesized as a significant factor related to hip and pelvis motion during running.  
However, this variable was not a significant predictor of hip adduction or hip internal 
rotation excursion in our model.  To further investigate this finding, Chapter IV uses a 
hip abductor fatigue protocol in order to look at inter-subject changes in running 
kinematics after hip abduction strength is decreased. 
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CHAPTER IV 
THE EFFECT OF DECREASED HIP ABDUCTION STRENGTH ON RUNNING 
KINEMATICS AND HIP MUSCLE ELECTROMYOGRAPHY 
 
This chapter contains co-authored material.  JJ Hannigan was responsible for the 
conceptual development, development of the protocol, data collection and analysis, and 
writing of the manuscript.  Dr. Li-Shan Chou contributed to the conceptual development 
and refinement of the protocol, and provided critiques and editing for the manuscript.   
 
 
Introduction 
 Most literature agrees that females with PFPS have weaker hip abductor muscles, 
(11,23,52,71,93,101), and greater hip adduction (74,80–82,115,119) and hip internal 
rotation (81,82,101) during running than healthy females.  However, based on previous 
literature, as well as the results of Chapter III, any relationships between hip strength and 
hip kinematics appear tenuous at best (4,32,46,48,100,120,125).  One limitation of 
studies investigating the hip strength-hip kinematics relationship in runners is that they 
are either cross-sectional, or investigate changes in kinematics over a 4-8 week period of 
strengthening, where subjects can slowly adapt to increasing strength, and measurement 
reliability decreases between visits (29).   
While muscle strength cannot be substantially increased during a single visit, the 
maximum torque-generating capacity of a muscle can be decreased after fatigue, by 
inducing muscle damage, or both (37,61,76).  Decreasing hip abduction strength appears 
to alter spatiotemoporal parameters during walking (3), movement strategies during static 
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balance control (7,61,76), and knee joint moments during cutting, jumping, landing, and 
running (37,85).  However, decreasing hip abduction strength does not appear to 
significantly affect frontal plane hip and knee biomechanics during walking (88) or hip 
kinematics during running (37). 
 One potential avenue to assimilate these findings is investigating how trunk 
control is modulated with changes to hip abduction strength.  It has been suggested, but 
not yet explored, that compensatory movements at the trunk may help explain how knee 
joint moments are altered without changes to hip and knee kinematics (100).  We also do 
not currently know whether fatiguing and inducing muscle damage in the hip abductor 
muscles will affect hip muscle activation during running.  Thus, the primary purpose of 
this study was to investigate kinematic and electromyographic differences during running 
before and after a hip abductor fatigue protocol.  It was hypothesized that only trunk 
kinematics would be affected by the fatigue protocol. 
 In addition, because of cited sex differences in PFPS injury rates (106), running 
kinematics (31,86), and hip muscle activation during running (116), the effect of sex 
appears to be an important consideration when investigating this relationship.  Therefore, 
this analysis will investigate whether males or females respond differently to decreasing 
hip muscle strength. 
 
Methods 
Fatigue Protocol Validation 
 Before proceeding with the main study, the fatigue protocol used to decrease hip 
abduction strength needed to be validated.  To be included in the fatigue protocol 
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validation study, subjects needed to be between 18-45 years old, recreationally active for 
at least 30 minutes three days per week, and report no major injuries over the past six 
months (6,21).  Prior to participation, subjects signed an informed consent form approved 
by the Institutional Review Board at the University of Oregon.  
For this protocol, subjects first warmed up for five minutes on the treadmill.  
Subjects were then positioned sidelying on the padded treatment table with the greater 
trochanter of the dominant leg aligned with the dynamometer arm and the resistance pad 
attached firmly to the thigh three finger lengths above the joint line.  The dominant leg 
was defined as the leg a subject would kick a soccer ball for distance.  Subjects then 
performed three maximum isometric efforts in the direction of abduction with the hip in 
neutral position, separated by five seconds.  The mean peak torque between these efforts 
was considered the subject’s baseline hip abduction strength. 
Subjects were then given explicit instructions for the fatigue protocol, and 
researchers ensured subjects were comfortable with the protocol before proceeding.  The 
fatigue protocol was a dynamic two-minute task, as the arm of the dynamometer rotated 
at 30º per second through a 30º range of motion, regardless of the subject’s exerted 
torque.  All subjects were instructed to push in the direction of abduction for two minutes 
while the dynamometer rotated through this range of motion, with specific instructions to 
try to resist the dynamometer as it rotated downward.  Thus, when the dynamometer 
rotated upward, the hip abductor muscles were contracting concentrically, and when the 
dynamometer rotated downward, the hip abductor muscles were contracting 
eccentrically.  Subjects were given visual feedback of their torque production during the 
entire task, and were instructed to focus on keeping their torque above zero.  Subjects 
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were also specifically instructed to push as hard as they could during the last 15 seconds 
and not give up during the protocol, so that they did not begin to rest early.  Subjects 
were given verbal encouragement and feedback on time remaining during the test.   
 During the validation protocol only, subjects then remained attached to the 
dynamometer and were asked to produce a set of three maximal isometric efforts into 
abduction in a neutral hip position every two minutes, until ten minutes total had elapsed 
after the fatigue protocol.  This was performed to track the recovery of hip abduction 
strength.  In addition, subjects self-reported their hip abductor fatigue on a visual analog 
scale (VAS) before the protocol, immediately after the protocol, and 10 minutes after the 
protocol by making a mark on a line 10 cm long, with 0 indicating no perceived fatigue in 
the hip abductors, and 10 indicating the most fatigue imaginable.  VAS scores were then 
calculated on a scale of 1-10 for analysis. 
Protocol – Running Study 
To be eligible for the main running study, subjects needed to be between 18-45 
years old (81,101), average running at least 20 miles per week (129), and report no major 
injuries for at least the previous 6 months (6,21).  A major injury was consistent with the 
consensus definition by Yamato el al. (127).  All subjects signed an informed consent 
form approved by the University of Oregon (Appendix B). 
 Subjects warmed up at their easy pace on a treadmill for five minutes.  Hip 
abduction strength for the dominant limb was then tested in sidelying position on the 
Biodex System 3 dynamometer (Biodex Medical Systems, Shirley NY) (Figure 1).  The 
dominant limb was again defined as the leg subjects would prefer to kick a soccer ball for 
distance.  In total, hip abduction strength was tested four times throughout running study 
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protocol.  Subjects were given real-time visual feedback of their hip abduction torque via 
a computer monitor for all tests. 
Subjects were then outfitted with a vest attached to a 6-channel EMG backpack 
with adjustable gain (MA-300, Motion Lab Systems, Baton Rouge LA) (Figure 4A).  
Prior to electrode placement, the skin was lightly abraded and cleaned with an alcohol 
pad over the site of electrode placement locations.  Six pre-amplified electrodes (Figure 
4B) and one ground electrode were then placed directly on the skin.  Conducting gel was 
placed between the skin and electrodes and several strips of white athletic tape secured 
the electrodes to the skin.  The active electrodes were placed on the tensor fascia latae 
(TFL), gluteus medius (GMED) and gluteus maximus (GMAX) bilaterally.  The 
positioning of electrodes can be seen in Figure 4C. 
The EMG pre-amplifier contained a band-pass filter from 20 to 500 Hz and a gain 
of 20.  The gain was then manually adjusted at the backpack, set at 4000 unless this 
produced signal clipping during the MVIC.  This signal was then fed to a desktop 
amplifier (gain = 2) via a coaxial connection cable which transmitted the analog signal 
through a 12-bit A/D board connected to the motion capture computer in the Motion 
Analysis Laboratory.  This signal was collected at 1000 Hz using Cortex 5 motion 
capture software (Motion Analysis Corporation, Santa Rosa CA) so that EMG and 
motion capture data would be synchronized.  The signal to noise ratio was visually 
inspected as the subject performed standing hip abduction and hip extension.  If the 
signal to noise ratio was not acceptable, slight adjustments were made to the electrode 
placement and the signal to noise ratio was retested. 
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Maximum voluntary isometric contractions (MVICs) were then performed on a 
padded treatment table.  For the gluteus maximus MVIC, the subject was positioned 
prone with the knee flexed to 90º (116,117).  Two stabilization straps were tightly 
attached just distal to the gluteal fold and just proximal to the popliteal fossa on one leg.  
A researcher also helped stabilize the subject by placing their hands on the thigh during 
the test.  Subjects were instructed to push up against the straps using their gluteal muscle 
with maximal force for five seconds.  This was repeated for the same leg after 45 seconds 
and was then repeated on the opposite leg. 
MVICs for gluteus medius and TFL were performed with the subject sidelying and 
the hip in 0º of flexion and rotation, and 10º of abduction.  Two stabilization straps were 
attached just proximal to the knee and just proximal to the ankle with tautness that would 
allow 10º of abduction.  Similar to GMAX MVIC testing, a researcher helped stabilize 
their leg during testing to avoid the subject rotating their body.  Subjects were instructed 
to push up against the straps using their hip abductor muscles with maximal force for five 
seconds.  This was repeated for the same leg after 45 seconds and was then repeated on 
the opposite leg. 
Subjects were then outfitted with 39 reflective markers (6,41).  The trunk segment 
was defined by two markers on the acromion processes, as well as a virtual marker at the 
pelvis center of mass (81).  The pelvis was defined by two markers on the anterior 
superior iliac spines, and one at the midpoint between the posterior superior iliac spines.  
The femur was defined by two markers at the medial and lateral femoral epicondyles, and 
one marker mid-thigh in line with the lateral epicondyle and greater trochanter.  The hip 
joint center was defined by measurements of ASIS breadth (112).  The shank was defined 
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by the epicondyle markers, two markers on the medial and lateral malleoli, and a marker 
on the medial shank. 
Subjects then ran continuous laps of approximately 40-meters in the Motion 
Analysis Laboratory at their easy run pace while whole body kinematics were collected 
with a 10-camera motion capture system (Motion Analysis Corp., Santa Rosa CA) 
sampling at 200 Hz.  This pace was defined as the pace a subject could comfortably 
maintain for 30 minutes while maintaining a conversation.  Participants were instructed 
not to alter their stride to hit three force plates (AMTI, Watertown, MA) located in series 
in this region.  Subjects were given two laps to become accustomed to running in the lab 
before data was collected.  Subjects then completed 20 laps in the laboratory.  Data were 
collected when the participants passed through a straight 10-meter region in the center of 
the capture volume.  
After running 20 laps in the lab, hip abduction strength was tested again on the 
dynamometer.  For this test, subjects only pushed one time for five seconds.  If subjects 
did not meet or exceed their previous maximum hip abduction torque, the test was 
performed one more time. 
Subjects were then given instructions for the fatigue protocol.  The instructions 
and procedures for the protocol itself were the exact same as during the protocol 
validation.  Immediately after the two-minute fatigue protocol, within approximately 3-5 
seconds, subjects performed one maximum isometric effort in the direction of abduction.  
This was done to assess the decrease in hip abduction torque immediately following the 
protocol.  
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Subjects then immediately were detached from the Biodex machine and began 
running again in the lab.  Twenty laps were again completed while whole body 
kinematics were collected by the motion capture system.  After running, subjects 
performed one more isometric hip abduction strength test – three efforts separated by 
fifteen seconds. 
Data Processing and Analysis 
 To quantify hip abduction strength at the first and last time point (three efforts), 
mean maximal torque was calculated by averaging the peak torque generated during each 
three effort.  To quantify hip abduction strength during the second and third time points, 
the maximum torque generated during the one five-second effort was calculated.  For all 
tests, the hip abduction torque was normalized by body mass for analysis. 
 Five running trials per limb per subject were selected for analysis (116,117) for 
both pre-fatigue and post-fatigue running.  Only trials where the foot cleanly struck a 
force plate were selected.  Foot strike was defined as the first frame where the vertical 
ground reaction force exceeded 50 Newtons (N), and toe off was defined as the first 
frame where the vertical ground reaction force fell below 50 N (14).  During the post-
fatigue running task, all trials analyzed were within the first 10 laps to minimize any 
kinematic changes as hip abduction strength recovered while running.  
Marker trajectories were identified using Cortex 5.0 motion capture software 
(Motion Analysis Corp., Santa Rosa CA) and were smoothed using a low-pass, fourth-
order, zero-lag Butterworth filter with an 8 Hz cutoff.  A custom LabView program 
(National Instruments, Austin TX) calculated hip angles during stance phase using a 
YXZ cardan angle rotation sequence.  Angular excursions and peak angles in all the 
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planes at the knee, hip, pelvis, and trunk were calculated.  Peak angles were defined as 
the maximum joint or segment angle during stance phase.  Angular excursion was 
defined as the difference between the angle at initial contact and the peak angle during 
stance phase (4).  Excursions and peak angles were calculated for each trial and averaged 
for analysis. 
All EMG data were processed and analyzed using a custom LabView program.  
EMG data were band-pass filtered from 20-450 Hz, root-mean-square (RMS) averaged 
and smoothed using a 50 ms sliding window.  To determine the MVIC for each muscle, 
both trials were processed.  For both MVIC attempts, a sliding 500 ms window calculated 
the mean amplitude of the highest signal portion of the MVIC trial.  The highest value 
between trials was determined the MVIC value for each muscle.  
Running trials were trimmed to 250 ms before foot strike and 250 ms after toe off, 
respectively, for analysis.  Due to variability in the data, no set threshold above baseline 
was determined feasible to determine EMG onset.  Therefore, EMG onset and offset was 
defined by visual inspection, which has shown to be reliable (53).  EMG onset was 
defined as the first major vertical deflection of the EMG signal (53) during the 250 ms 
window before heel strike which remained above baseline for at least 25 ms (116,117).  
EMG offset was defined as the last major vertical deflection of the EMG signal (53) 
which remained below baseline for at least 25 ms (116,117).   EMG onset is represented 
numerically as the time in milliseconds before foot strike, while EMG offset is 
represented numerically as the time in milliseconds before toe-off (Figure 5).  EMG 
duration was calculated as the difference between the onset and offset times (Figure 5) 
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EMG peak amplitude was calculated as the maximum EMG recording within the 
visually determined onset and offset times (Figure 5).  This maximum EMG value was 
normalized by the MVIC for that muscle.  All four EMG parameters were then averaged 
between the five trials for analysis.  In rare cases where the mean peak amplitude 
exceeded 200% MVIC, this data point was discarded for analysis, as it was assumed the 
subject was not able to perform a true MVIC for that muscle. 
Statistical Analysis 
 A 2 x 2 mixed effects ANCOVA was calculated for peak joint angles, joint angle 
excursions, and EMG parameters to determine the effect of the fatigue protocol and sex 
on the dependent variables.  Because of a significant difference in running speed between 
bouts of running, percent change in running speed was entered as a covariate in the 
analysis.  An alpha-level of .05 was set for all omnibus tests.  Because each factor only 
contained two levels, no Bonferroni corrections for pairwise comparisons were 
warranted.  All statistics were calculated using SPSS version 23 (SPSS Inc., Chicago IL), 
except for effect sizes, which were calculated using G*Power 3.1 (G*Power, Düsseldorf, 
Germany). 
 
Results 
Fatigue Protocol Validation 
 Twelve subjects met the inclusion criteria and agreed to participate in the study 
fatigue protocol validation study, six males and six females (age: 25.5 ± 4.7 years, height: 
175.6 ± 6.8 cm, weight: 70.5 ± 9.8 kg).  On average, hip abduction torque immediately 
after the fatigue protocol significantly decreased by 27.4 ± 9.9%, p < .001.  Over the 
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course of 10 minutes, torque recovered fairly linearly, with hip abduction torque still 10.6 
± 6.6% decreased compared to baseline, p = .001 (Figure 6).   
VAS scores significantly increased from before the fatigue protocol (0.43 ± 0.55) 
to immediately after the fatigue protocol (7.44 ± 1.99), p < .001.  VAS scores remained 
elevated 10 minutes after the protocol (5.43 ± 2.79), which was still significantly greater 
than before the fatigue protocol, p < .001 (Figure 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Average percent reduction in hip abduction torque immediately following 
the two minute fatigue protocol, and every two minutes for ten minutes. 
Figure 7. Visual analog scale perception of fatigue immediately before, immediately 
after, and ten minutes after the fatigue protocol. 
 62 
 
Running Study 
 Thirty subjects (15 males and 15 females) met the inclusion criteria and were 
included in this study.  Subject demographics can be seen in Chapter II (Table 1). 
Hip abduction torque significantly decreased by an average of 31.8 ± 15.5% 
following the fatigue protocol (p < .001, effect size = 1.56), and remained significantly 
lower (9.1 ± 9.4%) after the second bout of running (p < .001, effect size = 0.80) (Figure 
8).  There was no interaction effect between time and sex, nor main effect of sex.  On 
average, there was 44.0 ± 12.9 seconds between the end of the fatigue protocol and when 
subjects began the second bout of running, and 6 minutes and 52 seconds (± 96 seconds) 
between the end of the fatigue protocol and the final hip abduction strength test.  Running 
speed did significantly increase from before the fatigue protocol (2.98 ± 0.28 m/s) to after 
the fatigue protocol (3.07 ± 0.29 m/s), p = .004. 
 
 
Figure 8. Hip abduction strength measured at four distinct time points 
 63 
 
There was no significant interaction effect for peak angles at the knee, hip, or 
pelvis.  There was a significant fatigue by sex interaction for trunk flexion (p = .004), as 
trunk flexion significantly decreased following fatigue in males (pre-fatigue: 9.61º; post-
fatigue: 8.80º; p = .035), and increased following fatigue in females (pre-fatigue: 8.90º; 
post-fatigue: 9.84º; p = .021).  Peak knee flexion significantly decreased (p = .002), while 
peak ipsilateral trunk lean significantly increased (p = .006) after the fatigue protocol 
(Figure 9; Table 12).  There was no main effect of sex for any variable. 
 There were no interaction effects for any joint excursions at the knee, hip, pelvis, 
or trunk.  Pelvic rotation excursion (p = .011) and ipsilateral trunk lean excursion (p = 
.011) significantly increased after the fatigue protocol, while trunk rotation excursion 
significantly decreased (p = .008) (Figure 10; Table 13).  In addition, females 
demonstrated greater hip rotation excursion (females: 8.45 ± 3.38º; males: 6.00 ± 2.89º;  
p = .040), trunk flexion excursion (females: 3.95 ± 1.34º; males: 2.90 ± 1.16º; p = .031), 
and trunk rotation excursion (females: 27.87 ± 5.35º; males: 21.15 ± 4.35º p = .002) 
compared to males. 
 
 
 
 
 
 
 
 
 
 Figure 9. Peak angles of the knee, hip, pelvis, and trunk before and after the hip 
abductor fatigue protocol 
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Table 12. Peak joint angles before and after the hip abductor fatigue protocol 
* Indicates a significant difference between conditions, p < .05. 
 
 
 
 
 
 
 
 
Peak Angles (º) Pre-Fatigue Post-Fatigue p-value Effect Size 
Knee Flexion 42.29 ± 5.86 41.51 ± 5.49 0.002* 0.654 
Knee Valgus 4.00 ± 6.03 3.92 ± 6.18  0.847 0.061 
Hip Extension 9.90 ± 3.55 10.53 ± 4.98 0.681 0.294 
Hip Adduction 12.83 ± 3.04 13.06 ± 3.48  0.812 0.154 
Hip Internal 
Rotation 
5.20 ± 10.6 5.65 ± 10.8 0.381 0.144 
Pelvic Tilt 3.27 ± 6.53 2.72 ± 6.93 0.151 0.231 
Pelvic Drop 5.84 ± 2.17 5.98 ± 2.71 0.569 0.103 
Pelvic Rotation 4.86 ± 3.33 5.50 ± 3.41   0.955 0.305 
Trunk Flexion 9.42 ± 3.38 9.30 ± 3.52 0.471 0.019 
Trunk Lean 2.14 ± 1.73 2.83 ± 1.87 0.006* 0.773 
Trunk Rotation 12.35 ± 4.12 11.78 ± 3.86   0.140 0.092 
Figure 10. Angular excursions of the knee, hip, pelvis, and trunk before and after the 
hip abductor fatigue protocol 
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Table 13. Angular excursions before and after the hip abductor fatigue protocol 
* Indicates a significant difference between sexes, p < .05 
 
There were no interaction effects for any EMG variable.  TFL offset significantly 
decreased (i.e., occurred closer to toe off during stance phase) (p = .022) and TFL 
duration significantly increased (p = .045) after the fatigue protocol.  GMAX peak 
amplitude (p = .050) and GMAX duration (p = .032) also significantly increased after the 
fatigue protocol (Table 14).  Finally, GMAX onset occurred significantly earlier in males 
compared to females (females: 30.38 ± 24.90 ms; males: 61.10 ± 26.6 ms; p = .004). 
Because we did not see any differences in peak angles or excursions for hip 
adduction and hip internal rotation, but did see changes at the knee, pelvis, and trunk, we 
performed post-hoc correlations between the percent decrease in hip abduction torque 
and percent increase for several kinematic variables (Tables 15-16).  There was a 
significant correlation between the percent decrease in hip abduction torque, and the 
percent increase in peak trunk lean (r = 0.394, p = .030) (Table 16). 
 
 
Excursions (º) Pre-Fatigue Post-Fatigue p-value Effect Size 
Knee Flexion 24.84 ± 4.34 24.33 ± 4.17 0.099 0.330 
Knee Valgus 2.79 ± 3.28 3.01 ± 3.24  0.225 0.209 
Hip Extension 40.17 ± 3.81 40.08 ± 4.46 0.260 0.038 
Hip Adduction 4.41 ± 2.36 4.95 ± 2.75  0.283 0.278 
Hip Internal 
Rotation 
6.90 ± 3.37 7.55 ± 3.53 0.720 0.239 
Pelvic Tilt 4.74 ± 1.43 5.42 ± 1.79 0.163 0.466 
Pelvic Drop 2.84 ± 1.33 3.46 ± 1.89 0.244 0.359 
Pelvic Rotation 2.60 ± 2.70 3.14 ± 2.81   0.011* 0.686 
Trunk Flexion 3.56 ± 1.21 3.23 ± 1.33 0.108 0.516 
Trunk Lean 1.32 ± 0.77 1.58 ± 0.84 0.018* 0.681 
Trunk Rotation 24.89 ± 5.35 23.89 ± 5.83   0.008* 0.414 
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Table 14. EMG variables before and after the hip abductor fatigue protocol 
(Amplitude = % MVIC; Onset, Offset, Duration = ms) 
* Indicates a significant difference between sexes, p < .05. 
 
Table 15. Correlations between % decrease in hip abduction strength and % increase in 
hip kinematics before and after the hip abductor fatigue protocol 
 
Table 16. Correlations between % decrease in hip abduction strength and % increase in 
pelvis and trunk kinematics before and after the hip abductor fatigue protocol 
* Indicates a significant correlation, p < .05. 
 
 
 
 
 Pre-Fatigue Post-Fatigue   p-value Effect Size 
TFL Amplitude 94.37 ± 55.11 104.68 ± 81.71 0.462 0.198 
TFL Onset 40.83 ± 33.05 39.21 ± 26.29   0.762 0.101 
TFL Offset 78.41 ± 21.23 64.71 ± 24.75 0.022* 0.628 
TFL Duration 209.72 ± 39.30 216.93 ± 35.83 0.045* 0.270 
GMED Amplitude 86.31 ± 44.42 86.73 ± 38.84   0.645 0.008 
GMED Onset 21.90 ± 25.15 24.93 ± 35.56 0.339 0.094 
GMED Offset 78.90 ± 26.75 72.68 ± 31.19 0.809 0.295 
GMED Duration 192.03 ± 28.98 195.14 ± 39.00 0.427 0.083 
GMAX Amplitude 75.75 ± 34.20 90.72 ± 49.58  0.050* 0.389 
GMAX Onset 42.43 ± 28.46 48.83 ± 30.84 0.107 0.302 
GMAX Offset 70.83 ± 20.37 61.03 ± 29.38  0.086 0.394 
GMAX Duration 218.80 ± 34.15 230.52 ± 34.18  0.032* 0.347 
 
Hip Adduction 
Excursion 
Peak Hip 
Adduction 
Hip Internal 
Rotation Excursion 
Peak Hip Internal 
Rotation 
% Decrease r  = 0.072 r  = 0.072 r  = -0.206 r  = 0.132 
 
Pelvic Rotation 
Excursion 
Trunk Lean 
Excursion 
Peak Trunk Lean 
Peak Knee 
Flexion 
% Decrease r  = 0.021 r  = 0.333 r  = 0.394* r  = 0.132 
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Discussion 
 The main purpose of this study was to investigate changes in running kinematics 
and hip muscle activation after a hip abductor fatigue protocol.  The hip abductor fatigue 
protocol significantly decreased hip abduction torque immediately after the protocol, and 
remained significantly lower after the second bout of running.  However, there were no 
significant changes in the amplitude or timing of the gluteus medius, the primary hip 
abductor muscle, and no significant differences in kinematics at the hip.  Small changes 
at the knee, pelvis, and trunk, as well as alterations in TFL and GMAX muscle activity, 
were seen following the fatigue protocol. 
Because the fatigue protocol consisted of repeated, maximal eccentric 
contractions for the hip abductors, this protocol likely induced muscular damage, 
especially in the gluteus medius.  In addition, metabolites likely accumulated in the hip 
abductor muscles during the protocol.  The decreased capacity of the hip abductor 
muscles to produce force after the protocol is probably due to a combination of these 
factors.  Despite the probability of muscle damage and metabolite buildup, gluteus 
medius peak amplitude and timing during running gait were not affected.  Other 
kinematic and EMG variables, however, appear to have been affected by the decrease in 
hip abduction strength. 
Both peak ipsilateral trunk lean and trunk lean excursion increased following the 
fatigue protocol, with moderate effect sizes for both variables (Figure 9; Table 13).  
While the absolute changes in trunk lean magnitude were relatively small, peak trunk 
lean increased in 25 out of 30 subjects, and the correlation between the percent decrease 
in hip abduction strength and the percent increase in peak trunk lean after the fatigue 
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protocol was significant (Table 16), indicating that hip abduction strength may be a 
significant modulator of frontal plane trunk motion during running.   
 Increased lateral bending of the trunk towards the stance limb should decrease 
the moment arm of the center of mass relative to the hip joint center (91).  Thus, the 
increase in trunk lean towards the stance limb after hip abductor strength is decreased is 
likely an attempt to offload the hip abductor muscles during running.  Due to the 
influence of frontal plane trunk position on the COM moment arm, these small alterations 
in trunk position could have a substantial impact on frontal plane hip and knee moments 
and impulses during running (103,105).  While this study did not look at knee joint 
moments, previous work indicates that isolated hip abductor fatigue does shift the 
external knee joint moment in the valgus direction (37).  This biomechanical 
compensation is theorized to increase the tensile stress on the knee, possibly increasing 
the risk of significant injury (91). 
 Peak knee flexion significantly decreased following the hip abductor fatigue 
protocol, meaning the knee was slightly more extended during midstance.  Lenhart et al. 
(2014) reported a significant positive correlation with peak knee flexion angle and 
patellofemoral joint force (64).  Thus, the decreased peak knee flexion angle observed in 
this study would likely mean that peak patellofemoral force at the knee decreased 
following the fatigue protocol.  If greater ipsilateral trunk lean has negative consequences 
to knee joint forces, decreasing knee flexion could be an attempt to counteract the 
deleterious changes at the trunk. 
 We observed a fatigue by sex interaction effect for peak trunk flexion, as peak 
trunk flexion decreased in males and increased in females after the fatigue protocol.  
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GMAX peak amplitude also increased in both males and females after the fatigue 
protocol, and GMAX onset was overall earlier in males than females.  In addition to 
being the primary hip extensor muscle during running, gluteus maximus also acts to 
control forward trunk flexion during running (66).  Gluteus maximus amplitude has a 
strong negative correlation with the rate of trunk flexion during the first half of stance 
phase (66), meaning that greater amplitude is associated with slower rates of flexion.  
Because of the decrease in hip abduction strength, an increase in GMAX peak amplitude 
may be a compensatory mechanism to increase trunk stability during running.  In males, 
it thus makes sense that GMAX peak amplitude increased while peak trunk flexion 
decreased after fatigue, especially given that GMAX onset occurred earlier overall in 
males. 
 The relationship between GMAX amplitude and peak trunk flexion following the 
fatigue protocol in females, however, appears somewhat paradoxical.  Despite an increase 
in GMAX peak amplitude, females also demonstrated increased peak trunk flexion after 
the fatigue protocol.  Females, on average, ran with greater trunk flexion than males 
(35,46,97), and also may run with greater peak GMAX amplitude relative to their MVIC 
compared to males (116).  One possible explanation is that in females, gluteus maximus 
is recruited at a higher percent of maximum, partially as a result of trying to control 
excessive trunk flexion, which may have been exacerbated after the fatigue protocol.  It is 
also possible that recruiting gluteus maximus at a higher percentage of maximum during 
running means that gluteus maximus fatigue occurs sooner, resulting in greater trunk 
flexion.  Greater amounts of trunk flexion are not bad however – quite the opposite, as 
increasing trunk flexion is associated with decreasing patellofemoral joint stress, and thus 
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may be injury-protective (108).  It is interesting that females, who have a higher risk of 
developing patellofemoral pain, demonstrate an injury-protective movement toward 
greater peak trunk flexion.  The relationship between trunk flexion during running, 
GMAX amplitude during running, and the risk of knee injury in females appears to 
require further research. 
 Pelvic rotation excursion increased after the fatigue protocol in both sexes, which 
is not surprising given gluteus medius is thought to be help control transverse plane 
pelvis motion during locomotion (39).  Hip abduction strength has also been moderately 
correlated with pelvic rotation excursion in males during running (46).  Thus, decreasing 
hip abduction strength appears to limit the ability of the hip abductor muscles to control 
pelvis motion in the transverse plane.   
Trunk rotation excursion significantly decreased in both sexes after the fatigue 
protocol, and trunk rotation excursion was greater in females compared to males overall.  
Thus, trunk rotation in all three planes appears to be affected by decreasing hip abduction 
strength.  Peak trunk rotation generally occurs at toe off.  Decreased trunk rotation 
excursion, but not peak trunk rotation, thus may indicate that the trunk is slightly more 
rotated toward the stance limb at foot strike, which may also be an attempt to offload the 
hip abductor muscles. 
TFL duration increased, and TFL offset time occurred significantly closer to toe-
off.  This compensation may be an attempt of the other major hip abductor muscle to 
provide stability to the hip joint after maximum strength was compromised. 
Given these changes in kinematics and EMG, it is still unclear why GMED 
parameters did not change.  Greater trunk lean should decrease the amount of force 
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gluteus medius needed to contract.  While force generally scales with EMG (either 
linearly or non-linearly), this relationship is not as clear under dynamic activities, and at 
higher percentages of MVIC (58).  It is possible that the combination of muscle damage 
and neuromuscular fatigue was not high enough to affect the nervous input to the muscle.  
It is also possible that the subjects, knowing their muscle strength was diminished, 
attempted to consciously recruit their affected hip abductor muscles, overcoming any 
deficits in nervous input after fatigue. 
It is also important to point out that while hip kinematics did not change overall, 
some subjects did have considerable changes to hip kinematics.  Every subject likely 
compensates differently to the hip abductor fatigue protocol, depending on many factors, 
not limited to their relative strength pre-fatigue and the amount of torque reduction after 
fatigue.  Further analyses could look to identify subgroups of runners based on their 
compensation patterns. 
 This study is not without several limitations.  First, running speed before and after 
fatigue was not tightly controlled.  While runners were instructed to run at the same pace, 
several runners slightly increased their running speed after the fatigue protocol, likely due 
to adrenaline.  Running speed was accounted for as a covariate in the statistical analysis 
to help mitigate this difference.  In addition, there was almost a significant difference in 
average mileage between males and females, with males averaging almost 10 miles more 
per week compared to females.  Thus, we cannot say for certain whether some sex 
differences may be partly due to relative training volume.  Foot strike patterns were not 
controlled in this study, so we cannot say whether any changes after hip abductor fatigue 
vary per foot strike pattern.  In addition, all subjects wore their self-selected shoes, so that 
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introducing a new shoe was not a confounding variable.  It is unclear whether a different 
shoe type could mitigate or enhance any effects of decreased hip abduction strength.  
Finally, surface EMG measures have several inherent limitations, such as muscle cross 
talk, movement artifact, and electrode placement errors, which can negatively affect the 
quality of EMG data.   
 In conclusion, decreasing hip abduction strength in runners did not change gluteus 
medius amplitude or timing, and did not affect hip joint kinematics.  However, we did see 
changes in both distal and proximal kinematics, and gluteus maximus and TFL EMG, 
which may have injury implications. 
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Bridge 
 Chapters II-IV have investigated factors related to the neuromuscular control of 
the hip, pelvis, and trunk from a traditional biomechanical and neurophysiological 
perspective.  Chapter V uses a different technique to probe the neuromuscular control of 
the hip, called continuous relative phase, which can quantify coordination between 
adjacent segments.  This technique can be seen as an alternative method to investigate 
neuromuscular control of the hip. 
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CHAPTER V 
DOES HIP ABDUCTION STRENGTH OR SEX AFFECT COORDINATIVE 
VARIABILITY AT THE HIP DURING RUNNING?  
 
 This chapter contains co-authored material.  JJ Hannigan was responsible for the 
conceptual development, development of the protocol, data collection and analysis, and 
writing of the manuscript.  Dr. Li-Shan Chou contributed to the conceptual development 
and refinement of the protocol, and provided critiques and editing for the manuscript. 
 
Introduction 
 Traditional biomechanical analyses of human movement generally involve 
quantifying kinematic or kinetic parameters, such as individual joint angles, velocities, or 
moments.  While this approach has successfully identified risk factors for overuse injury, 
the underlying mechanisms for injury and relationship between injury factors has 
remained elusive, likely because most injuries are multifactorial (44).  To combat this 
issue, some biomechanists over the past 20 years have begun studying injuries from a 
dynamical systems approach, which investigates human movement on a more 
macroscopic level, taking into account the contribution of multiple injury factors (43). 
 While there are several techniques for quantifying coordination in the dynamical 
system approach, such as vector coding and discrete relative phase, continuous relative 
phase (CRP) has recently gained support in the biomechanics community, specifically in 
the field of overuse and running-related injuries.  One reason for its preference is the 
inclusion of both temporal and spatial information in its calculation, which provides 
“higher-dimensional” information compared to other measures (42,44).  Second, CRP 
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can take into account the entire gait cycle or stance phase of any movement, unlike other 
measures, which only analyze coupling at discrete time points during a movement 
(42,44). 
Central to the dynamical systems approach is the concept of coordinative 
variability, which needs to be distinguished from end-point variability.  Some tasks 
require low end-point variability, where the end result of a task must be tightly 
controlled, such as hitting a bulls-eye in darts.  In contrast, coordinative variability refers 
to the coordination of all joints and segments required to produce movement to perform 
the task (42).  Continuing with the darts example, this would refer to the coordinated 
movement between the shoulder, elbow, wrist, hand, and fingers needed to throw the 
dart.  While experts at a task such as dart-throwing may display lower end-point 
variability than novices, evidence suggests that experts may display greater coordinative 
variability than novices for that task (2). 
 Low coordinative variability also appears related to injury risk.  In theory, low 
coordinative variability between adjacent segments may lead to repetitive loading of the 
same structures and has been implicated in several overuse injuries (42,44,69).  In 
runners with PFPS, decreased coordinative variability was found between the thigh and 
shank and between the shank and foot segment (18,42).  In addition, females have 
demonstrated decreased coordinative variability compared to males during an 
unanticipated cutting maneuver, which may help explain the female sex bias for ACL 
tears (89). 
Despite the proposed link between both hip abduction strength 
(11,23,52,71,93,101) and hip kinematics (74,80–82,101,115,119) on PFPS injury risk, as 
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well as the female sex bias for PFPS (106), no study to date has looked at CRP variability 
at the hip, analyzed the relationship between hip strength and CRP variability, or 
compared CRP variability between sex during running.  Therefore, the primary purposes 
of this study were to a) investigate the effect of decreasing hip abduction strength on CRP 
variability during running, and b) compare CRP variability at the hip between sexes. It 
was hypothesized that CRP variability would increase after hip abductor fatigue, and be 
lower in females compared to males.  
 
Methods 
To be included in the study, subjects needed to be between 18-45 years old 
(81,101), average running at least 20 miles per week (129), and report no major injuries 
for at least the previous 6 months (6,21).  A major injury was consistent with the 
consensus definition by Yamato el al. (127).  All subjects signed an informed consent 
form approved by the University of Oregon (Appendix B). 
 Subjects warmed up at their easy pace on a treadmill for five minutes.  Hip 
abduction strength for the dominant limb was then tested in sidelying position on the 
Biodex System 3 dynamometer (Biodex Medical Systems, Shirley NY) (Figure 1).  The 
dominant limb was again defined as the leg subjects would prefer to kick a soccer ball for 
distance.  In total, hip abduction strength was tested four times throughout running study 
protocol.  Subjects were given real-time visual feedback of their hip abduction torque via 
a computer monitor for all tests. 
Subjects were then outfitted with 39 reflective markers (6,41).  The pelvis was 
defined by two markers on the anterior superior iliac spines, and one at the midpoint 
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between the posterior superior iliac spines.  The femur was defined by two markers at the 
medial and lateral femoral epicondyles, and one marker mid-thigh in line with the lateral 
epicondyle and greater trochanter.  The hip joint center was defined by measurements of 
ASIS breadth (112). 
Subjects then ran continuous laps of approximately 40-meters in the Motion 
Analysis Laboratory at their easy run pace while whole body kinematics were collected 
with a 10-camera motion capture system (Motion Analysis Corp., Santa Rosa CA) 
sampling at 200 Hz.  This pace was defined as the pace a subject could comfortably 
maintain for 30 minutes while maintaining a conversation.  Participants were instructed 
not to alter their stride to hit three force plates (AMTI, Watertown, MA) located in series 
in this region.  Subjects were given two laps to become accustomed to running in the lab 
before data was collected.  Subjects then completed 20 laps in the laboratory.  Data were 
collected when the participants passed through a straight 10-meter region in the center of 
the capture volume.  
After running 20 laps in the lab, hip abduction strength was tested again on the 
dynamometer.  For this test, subjects only pushed one time for five seconds.  If subjects 
did not meet or exceed their previous maximum hip abduction torque, the test was 
performed one more time. 
Subjects were then positioned sidelying on the padded treatment table with the 
greater trochanter of the dominant leg aligned with the dynamometer arm and the 
resistance pad attached firmly to the thigh three finger lengths above the joint line.  
Subjects were then given explicit instructions for the fatigue protocol, and researchers 
ensured subjects were comfortable with the protocol before proceeding.   
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The fatigue protocol was a dynamic two-minute task, as the arm of the 
dynamometer rotated at 30º per second through a 30º range of motion, regardless of the 
subject’s exerted torque.  All subjects were instructed to push in the direction of 
abduction for two minutes while the dynamometer rotated through this range of motion, 
with specific instructions to try to resist the dynamometer as it rotated downward.  Thus, 
when the dynamometer rotated upward, the hip abductor muscles were contracting 
concentrically, and when the dynamometer rotated downward, the hip abductor muscles 
were contracting eccentrically.  Subjects were given visual feedback of their torque 
production during the entire task, and were instructed to focus on keeping their torque 
above zero.  Subjects were also specifically instructed to push as hard as they could 
during the last 15 seconds and not give up during the protocol, so that they did not begin 
to rest early.  Subjects were given verbal encouragement and feedback on time remaining 
during the test.   
Immediately after the two-minute fatigue protocol, within approximately 3-5 
seconds, subjects performed one maximum isometric effort in the direction of abduction.  
This was done to assess the decrease in hip abduction torque immediately following the 
protocol.  Subjects then immediately were detached from the Biodex machine and began 
running again in the lab.  Twenty laps were again completed while whole body 
kinematics were collected by the motion capture system.  After running, subjects 
performed one more isometric hip abduction strength test – three efforts separated by 
fifteen seconds. 
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Data Processing and Analysis 
 To quantify hip abduction strength at the first and last time point (three efforts), 
mean maximal torque was calculated by averaging the peak torque generated during each 
three efforts.  To quantify hip abduction strength during the second and third time points, 
the maximum torque generated during the one five-second effort was calculated.  For all 
tests, the hip abduction torque was normalized by body mass for analysis. 
 Five running trials per limb per subject were selected for analysis (116,117) for 
both pre-fatigue and post-fatigue running.  Only trials where the foot cleanly struck a 
force plate were selected.  Foot strike was defined as the first frame where the vertical 
ground reaction force exceeded 50 Newtons (N), and toe off was defined as the first 
frame where the vertical ground reaction force fell below 50 N (14).  During the post-
fatigue running task, all trials analyzed were within the first 10 laps to minimize any 
kinematic changes as hip abduction strength recovered while running.  
Marker trajectories were identified using Cortex 5.0 motion capture software 
(Motion Analysis Corp., Santa Rosa CA) and were smoothed using a low-pass, fourth-
order, zero-lag Butterworth filter with an 8 Hz cutoff.  A custom LabView program 
(National Instruments, Austin TX) calculated pelvis and thigh angles and velocities 
during stance phase with respect to a global coordinate system using a YXZ cardan angle 
rotation sequence.  These values were interpolated to 100% of stance phase and 
normalized to values between -1 and 1 (13) using the following formulas (42):   
𝜽𝒊 =
𝟐 ∗ [𝜽𝒊 − 𝐦𝐢𝐧 (𝜽𝒊)]
𝐦𝐚𝐱(𝜽𝒊) − 𝐦𝐢𝐧 (𝜽𝒊)
 
𝝎𝒊 =
𝝎𝒊
𝐦𝐚𝐱 {𝐦𝐚𝐱(𝝎𝒊) , 𝐦𝐚𝐱 (−𝝎𝒊)}
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Phase portraits were constructed from these normalized segment angles (θ) (x-
axis) and velocities (ω) (y-axis) so that phase angles (φ) could be calculated using the 
following formula: 
𝛗 =  𝐭𝐚𝐧−𝟏(𝛚 𝛉⁄ ) 
Continuous relative phase (CRP) was then calculated by subtracting the phase 
angle of the thigh segment from the pelvis segment in both the frontal and transverse 
planes, respectively (42).  All trials for each subject were averaged to create an ensemble 
CRP curve for all three planes of motion, both pre and post-fatigue protocol.  Point-by-
point CRP variability was calculated by averaging the standard deviation at each percent 
of stance phase (42).  The overall variability of the CRP was also quantified for each 
runner by averaging the point-by-point variability for all 101 data points both before and 
after the fatigue protocol (15). 
Statistical Analysis 
 A three-way mixed effects ANCOVA was used to calculate the effect of sex, time 
(each 10% of stance phase), and fatigue (pre-fatigue and post-fatigue) on CRP variability 
of the dominant limb.  Because of a significant difference in running speed between bouts 
of running, percent change in running speed was entered as a covariate in the analysis.  
An alpha-level of .05 was set for all omnibus tests.   
To more closely analyze the effect of sex, both limbs were analyzed before the 
fatigue protocol using a mixed effects ANOVA.  The within-subjects factor was time 
(each 10% of stance phase), and the between subjects factors was sex.  All statistics were 
calculated using SPSS version 23 (SPSS Inc., Chicago IL). 
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Results 
 Thirty subjects (15 males and 15 females) met the inclusion criteria and were 
included in this study.  Subject demographics can be seen in Chapter II (Table 1).  The 
fatigue protocol significantly decreased hip abduction strength (Chapter IV, Figure 8). 
In the sagittal plane, there were no main interaction effects between any variable, 
and no main effect of fatigue or sex, p > .05 for all omnibus tests.  There was a significant 
main effect of time, p = .002.  Due to the number of pairwise comparisons, and relative 
unimportance of only comparing coordinative variability across stance phase for all 
subjects, these pairwise comparisons are not presented.  Sagittal plane CRP variability 
during stance phase in males and females both before and after the fatigue protocol can 
be seen in Figure 11. 
 In the frontal plane, there was a significant time by fatigue interaction, p = .037.  
Follow-up pairwise comparisons revealed that CRP variability significantly increased 
from 20-40% of stance phase after the fatigue protocol.  While the sex by time by fatigue 
interaction was not quite significant, pairwise comparisons in this analysis revealed that 
this increase in CRP variability from 20-40% of stance phase was mainly driven by 
increased variability in females.  Also in support of this claim, there was also a trending, 
but non-significant fatigue by sex interaction, p = .066.  Follow-up pairwise comparisons 
suggested that CRP variability increased in females after the fatigue protocol (pre-
fatigue: 22.38 ± 11.54º; post-fatigue: 29.92 ± 11.85º) (Figure 12). 
 In the transverse plane, no significant interaction or main effects were seen for 
any variable.  Transverse plane CRP variability during stance phase in males and females 
both before and after the fatigue protocol can be seen in Figure 13. 
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A 
B 
Figure 11. Sagittal plane CRP variability before and after fatigue in A) females and 
B) males.  There were no interaction effects or main effects of sex or fatigue. 
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Figure 12. Frontal plane CRP variability before and after fatigue in A) females and B) 
males.  CRP variability significantly increased after the fatigue protocol from 20-40% 
of stance phase, which was primarily driven by the overall increase in CRP variability 
in females. 
A 
B 
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Figure 13. Transverse plane CRP variability before and after fatigue in A) females 
and B) males.  There were no interaction effects or main effects for any variable. 
A 
B 
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 In the pre-fatigue sex comparison, there was no interaction effect, nor main effect 
of sex for sagittal plane CRP variability.  There was a main effect of time, p < .001 
(Figure 14).  In the frontal plane, there was no interaction effect, but there was a main 
effect of sex, with females displaying less CRP variability than males (males: 25.90 ± 
9.87º; females: 20.54 ± 9.87º; p = .040), and main effect of time, p < .001 (Figure 15).  In 
the transverse plane, there was no interaction effect, nor main effects for sex or time.  The 
main effect of sex was trending towards significance, however, p = .077 (Figure 16).  
Based on visual inspection of the data, a post-hoc analysis was performed on only the 
first 50% of stance phase.  This analysis did find a main effect of sex, with females 
displaying significantly less variability compared to males from 0-50% of stance phase 
(males: 41.26 ± 15.26; females: 32.82 ± 15.26º; p = .036). 
 
 
Figure 14. Sagittal plane CRP variability between males and females.  There was no 
interaction effect or main effect of sex. 
 86 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Frontal plane CRP variability between males and females.  There was a 
main effect of sex, with females displaying less CRP variability, p = .040. 
Figure 16. Transverse plane CRP variability between males and females.  There was 
no interaction effect, and the main effect of sex was trending towards significance,  
p = .077.  A post-hoc analysis indicated that females displayed significantly less CRP 
variability during the first 50% of stance phase, p = .036. 
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Discussion 
 One of the main purposes of this study was to investigate the effect of decreasing 
hip abduction strength on CRP variability at the hip.  Decreasing hip abduction strength 
did not significantly affect CRP variability in either the sagittal or transverse planes.  In 
the frontal plane, decreasing hip abduction strength significantly increased CRP 
variability from 20-40% of stance phase, which appears to be primarily driven an overall 
increase in CRP variability in females. 
 Greater coordinative variability, as seen in females after the fatigue protocol, is 
generally thought to be injury-protective, as it may help distribute joint loading across a 
greater contact area (44).  However, there may also be a threshold where coordinative 
variability is too high, as instability at a joint may predispose an individual to injury (44).   
Decreased hip abduction strength likely increases instability at the hip joint, which led to 
greater CRP variability in females.  Interestingly, average CRP variability was higher in 
females after the fatigue protocol (29.92 ± 11.85º) than in males before the fatigue 
protocol (25.90 ± 9.87º).  However, the exact threshold for excessive CRP variability is 
unclear (44), so the results from this study cannot determine whether decreased hip 
abduction strength may increase or decrease injury risk in females.   
 Comparing CRP variability between sexes before the fatigue protocol, females 
demonstrated less variability than males in the frontal plane.  Previous research suggests 
that healthy female runners run with greater peak hip adduction during running compared 
to healthy males (31), which may decrease contact area and increase contact stress on the 
lateral patella (50) as well as increase the external knee abduction moment (103).  Low 
frontal plane hip coordinative variability during midstance could thus elevate lateral 
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patellar contact stress even more by further decreasing the surface area available to 
distribute these high internal forces (44). 
 While not significant across the entire stance phase, females demonstrated greater 
CRP variability than males over the first 50% of stance phase.  This represents the 
loading phase of running, where impact forces rapidly increase joint stress, and muscular 
forces at the hip must decelerate the body’s center of mass and control hip internal 
rotation (102).  Healthy females, on average, run with greater hip internal rotation during 
running compared to males (31), which can increase lateral contact stress on the patella, 
especially if femoral rotation exceeds 20° (62).  Similar to the frontal plane, less CRP 
variability in the transverse plane in females may further increase contact stress on the 
lateral patella. 
 This study was not without a few limitations.  Running speed was not tightly 
controlled, as all subjects ran at their self-selected easy pace.  Running speed was not 
different between males and females (Chapter II, Table 1), but there was a small but 
significant increase in running speed after the fatigue protocol.  This change in running 
speed was controlled for as a covariate in the analysis.  Foot strike patterns were not 
controlled in this study, so it is not clear if coordinative variability at the hip is affected 
by the type of foot strike.  Running shoes were also not standardized in this study, so that 
coordinative variability was not affected by novel footwear.  CRP variability between 
different planes of motion was not analyzed in this study (i.e. transverse plane pelvis 
motion and frontal plane hip motion), which has been used to quantify coordination 
between distal segments during running (42).  Finally, this study did not look at 
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coordinative variability at the knee, which is the next logical step given that the knee is 
the actual site of injury in PFPS. 
 In conclusion, decreasing hip abduction strength increased frontal plane CRP 
variability at the hip from 20-40% of stance phase, primarily in females.  It is unclear 
whether this increase exceeds the threshold for excessive coordinative variability that 
may be indicative of injury.  Females demonstrated less CRP variability at the hip than 
males in the frontal plane, and during the first 50% of stance phase in the transverse 
plane, which may have implications for knee injury. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
Summary of Main Findings 
The overall aim of this study was to better understand the relationships between 
hip muscle strength, hip muscle activity, and running kinematics, particularly at the hip.  
Chapter II specifically looked at relationship between isometric hip muscle strength and 
hip muscle activation during running in both males and females.  Overall, hip strength 
and hip muscle activation during running were not strongly correlated, as the only 
significant correlation found was between hip abduction strength and TFL onset in 
females.  Because the TFL does not provide is not a large contributor to hip joint stability 
(65), this one finding likely does not have a substantial clinical implication.  Thus, the hip 
strength measurements used in clinical settings appear to not directly affect the amplitude 
or timing of hip muscle activation during running. 
This study also found that males displayed greater isometric hip flexion, internal 
rotation, and external rotation strength compared to females.  Importantly, no significant 
differences were seen in hip abduction strength between sexes.  This finding is in direct 
disagreement with many published studies, but does agree with previous findings from 
this laboratory (46).  In addition, females displayed delayed and shorter gluteus maximus 
activation, but greater relative amplitude compared to males.  Delayed gluteus maximus 
onset has been correlated to greater hip adduction and hip internal rotation excursion in 
females with PFPS (117).  Also, greater relative GMAX peak amplitude may lead to 
greater muscle fatigue and thus poorer dynamic control of the hip during prolonged 
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running (116).  Thus, these finding may help explain a one reason for the female sex bias 
in PFPS. 
The second study used a multiple regression approach to look for predictors of hip 
adduction and hip internal rotation during running.  For hip adduction excursion, sex, 
running speed, static subtalar inversion, and gluteus maximus amplitude were significant 
predictors in the model, with females displaying significantly greater hip adduction 
excursion compared to males.  GMAX amplitude’s inclusion in the model is interesting 
given the trend towards greater gluteus maximus activation in females from Chapter II.  
Based on the combined results of these studies, female sex, gluteus maximus activation, 
and hip adduction excursion all appear to be related.  It was hypothesized that runners 
with excessive hip adduction (as seen in more often in females) activate gluteus maximus 
at a higher percent of the maximum in an attempt to control frontal plane hip motion, 
meaning GMAX amplitude is less of a “predictor” and more of a “result” of greater hip 
adduction excursion.  This hypothesis, however, is purely speculation.   
The inclusion of static ankle inversion range of motion is a novel finding.  While 
it was hypothesized that greater available subtalar ROM may increase the available range 
of motion for hip adduction during running, this idea is also purely speculative and needs 
further exploration. 
Unfortunately, the only significant predictor in the hip internal rotation excursion 
model was sex, as females displayed significantly greater hip internal rotation excursion 
compared to males.  Thus, more work needs to be performed to determine any factors 
which may contribute to hip internal rotation excursion during running. 
 The third study examined the effect of decreasing hip abduction strength on 
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running kinematics and hip muscle EMG.  Neither hip kinematics nor gluteus medius 
activation changed after the fatigue protocol, which may help explain why hip 
strengthening programs do not change hip kinematics during running.  However, we did 
see some changes in kinematics, most notably at the trunk, with increased ipsilateral lean.  
This kinematic compensation is likely an attempt to offload the hip abductors, and may 
have a deleterious effect on the knee joint moment (37). 
 In addition, gluteus maximus peak amplitude and duration increased after fatigue, 
as did TFL peak amplitude.  Assuming that the dynamic control of the hip joint was 
hindered after the fatigue protocol, this finding further supports the notion that gluteus 
maximus activity increases to help control the thigh, especially in the frontal plane. 
 Finally, the fourth study used an alternative biomechanical method called 
continuous relative phase (CRP) to look the effect of sex and decreased hip abduction 
strength on CRP variability.  Decreasing hip abduction strength increased frontal plane 
CRP variability at the hip from 20-40% of stance phase, primarily in females.  It is 
currently unclear if this increase may exceed a threshold that increases injury risk is 
females.  Before the fatigue protocol, females demonstrated less CRP variability at the hip 
than males in the frontal plane and transverse planes.  Due to the relationship between hip 
adduction, hip internal rotation, and PFPS risk, decreased CRP variability may have 
profound injury implications and help explain the sex bias for PFPS. 
 
Clinical Implications 
Overall, the results from this study shed light on the relationships between hip 
strength, hip muscle activation, and kinematics during running in both males and females, 
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which may have implications for injury and rehabilitation strategies. 
First, hip muscle strength does not appear to be strongly correlated with hip muscle 
activation or hip kinematics during running.  Thus, if the goal of rehabilitation is to 
decrease “excessive” hip adduction, hip strengthening alone will likely be ineffective, and 
methods of gait retraining may be indicated.  However, hip strength may be an important 
modulator of trunk motion, which can have a substantial impact on knee joint loading 
(28,64).  Thus, hip muscle strengthening should still be an important component of 
rehabilitation for knee injuries. 
Gluteus maximus amplitude and timing appear to be different between males and 
females during running.  In addition, gluteus maximus amplitude appears to be related to 
hip adduction excursion, and may have an inverse relationship with hip abduction strength.  
While most research has focused on hip abduction strength and gluteus medius function 
during running, gluteus maximus appears to important in providing stability to the hip, not 
just forward propulsion, and may require increased attention during rehabilitation.  One 
method clinicians may utilize is increasing cadence, which has previously been shown to 
decrease gluteus maximus peak amplitude during (65).  Also, increasing hip extension 
strength may be warranted due the trending correlation between hip extension strength and 
GMAX onset seen in Chapter II. 
Finally, lower coordinative variability at the hip was seen in females in the frontal 
and transverse planes compared to males, which may have injury implications.  While 
coordinative variability appears to be a very useful biomechanical tool, its ability to 
enhancing clinical decisions is currently limited.  Thus, efforts need to be made to help 
bridge the gap between biomechanics and clinical application for this type of analysis. 
 94 
 
Directions for Future Research 
 This entire dissertation was comprised of data on healthy runners.  Thus, most of 
the discussion was centered around factors and relationships that “may have implications 
for injury”, or “may help explain the female sex bias for injury”.  The next logical step is 
to perform similar experiments on a cohort of males and females with patellofemoral 
pain.  Specifically, this future research could look at whether runners with PFPS display 
different relationships between the variables studied, demonstrate different 
compensations to decreased hip abduction strength, have lower coordinative variability at 
the hip compared to their healthy counterparts, or fatigue to a greater extent. 
 Other biomechanical techniques could be used to analyze this data.  Knee joint 
forces and moments were not analyzed in this study, but do have a significant 
relationship to knee injury.  In particular, it would be very interesting to quantify the 
effect of decreased hip abduction strength on knee joint moments.  Also, using 
musculoskeletal modeling software like OpenSim could also be used to estimate the 
effect of decreased hip abduction strength on hip muscle forces. 
 This dissertation mostly ignored the contribution of foot, ankle, and shank 
mechanics to the relationships studied.  It also only sampled EMG data from a very small 
subset of muscles.  Future studies could add in more distal contributions and EMG 
measures into similar comparisons. 
 Hopefully, the combination of findings from this dissertation, contributions from 
other researchers, and the future directions suggested will help clinicians improve the 
care and rehabilitation practices of runners suffering from patellofemoral pain syndrome. 
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APPENDIX A 
DATA COLLECTION FORMS 
Running Study Subject Questionnaire and Clinical Evaluation Form 
 
Subject Code: _______________  Date: _______________    
   
Sex: _________ 
Age: _________ 
Number of Years Running: ____________ 
Approximate Mileage Run per Week: _______________  
 
During your running career, have you sustained any running related injuries?  Yes/No 
 
If Yes, then please describe the nature of the injury, diagnosis by a physician, extent 
or duration of the injury, and treatment protocols you underwent to relieve symptoms:   
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
_____________________________________________________________________ 
 
Other Comments of History Information:  
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Subject #: _____________ 
 
 
 
 
 
 
 
 
 
 
 
Parameter Shod 
 L R 
Height (in cm)  
Body Mass (kg.)  
ASIS Width (cm)  
Thigh Length (cm)   
Mid-Thigh Circumference (cm)   
Calf Length (cm)   
Calf Circumference (cm)   
Knee Diameter (cm)   
Malleolus height (cm)   
Malleolus width (cm)   
Foot Length (cm)   
Foot Width (cm)   
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General Lower Body Alignment and Mobility Assessment 
 
1. Standing Leg Varus to Floor 
a. Left: ___________ 
b. Right: __________ 
 
2. Standing Arch Type: 
a. Left: ___________ 
b. Right: __________ 
 
3. Stork Test (normal or restricted) 
a. Left: ___________ 
b. Right: __________ 
 
4. Trendelenburg Test 
a. Left: ___________ 
b. Right: __________ 
 
5. Ankle Dorsiflexion  
 Extended Flexed 
Left   
Right   
 
6. Ankle Plantarflexion (flexed) 
a. Left: ___________ 
b. Right: __________ 
 
7. Subtalar Joint Inversion 
a. Left: ___________ 
b. Right: __________ 
 
8. Subtalar Joint Eversion 
a. Left: ___________ 
b. Right: __________ 
 
9. Forefoot Alignment (Neutral, 
Varus, Valgus) 
a. Left: ___________ 
b. Right: __________ 
 
 
 
 
10. 1st MPJ ROM (dorsiflexion) 
a. Left: ___________ 
b. Right: __________ 
 
11. Prone Hip Internal Rotation 
a. Left: ___________ 
b. Right: __________ 
 
12. Prone Hip External Rotation 
a. Left: ___________ 
b. Right: __________ 
 
13. Quadriceps Flexibility 
a. Left: ___________ 
b. Right: __________ 
 
14. Extremity Length (cm) 
a. Left: ___________ 
b. Right: __________ 
 
15. Hamstring 90-90 Test 
a. Left: ___________ 
b. Right: __________ 
 
16. Thomas Test 
a. Left: ___________ 
b. Right: __________ 
 
17. Ober’s Test 
a. Left: ___________ 
b. Right: __________ 
 
18. Tibial Torsion 
a. Left: ___________ 
b. Right: __________ 
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Measurement of Arch Height 
(from Williams, McClay, Hammill, and Buchanan (2001). Lower Extremity Kinetic and Kinematic 
Differences in High and Low Arched Runners. J. Applied Biomechanics.  Vol. 17, pp. 153-161) 
 
1.  Full Foot Length (cm):  L __________  R___________ 
2. 50% Full foot length (cm):  L __________  R___________ 
3. Truncated Foot Length ____________L  _____________R 
(measured from most posterior point of calcaneus to medial joint space of first metatarsal phalangeal 
joint). 
4.  Height of Dorsum of foot @ 50% foot length: __________L    ____________R 
5. Arch Height Ratio: _________ L   __________R 
(measurement 3 divided by measurement 4) 
 
Clinician Notes/Comments: 
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APPENDIX B 
INFORMED CONSENT FORM 
You are invited to participate in a research study conducted by doctoral candidate JJ 
Hannigan, MS, ATC and Drs. Li-Shan Chou, Louis Osternig, Stan James regarding the 
effect of hip muscle fatigue on hip muscle activity and running mechanics. You are being 
invited to participate because you are currently 18-45 years old and running greater than 20 
miles per week. 
 
TESTING PROCEDURES: If you decide to participate, you will visit the Motion Analysis 
Laboratory at the University of Oregon for 2-3 testing sessions.  During visit 1, body 
measurements, including height, weight, and leg length, will be measured.  You will then 
undergo a clinical exam assessing general lower limb alignment, flexibility, and joint 
mobility, which will take approximately 45 minutes to complete.  Next, we will test your hip 
muscle strength on a machine called a Biodex dynamometer, which measures how much 
muscle force you produce in a given direction.  You will be asked to push against the 
dynamometer in 6 different directions per leg.  These tests will take approximately 45 
minutes, totaling ~1.5 hours for visit 1.   
 
During Visit 2, after cleaning the skin with an alcohol solution, you will be fitted with 6 
pairs of active surface electrodes over 3 hip muscles in each leg, as well as 1 ground 
electrode.  These surface electrodes are tiny sensors that can detect the electrical activity of 
your muscles.  Hypo-allergenic conducting gel will be placed between the sensor and your 
skin to improve conductivity.  You will then be asked to perform a series of maximum 
voluntary isometric contraction (MVC) attempts for both hip abduction (pushing out to the 
side) and hip extension (pushing backwards) using the Biodex dynamometer.   
 
You will then be outfitted with 39 reflective markers and run overground for approximately 
10 minutes while your motion is recorded using the lab’s motion capture system, which uses 
special 3D cameras to track your motion.  After 10 minutes, you will undergo a hip abductor 
fatigue protocol, which will involve maximally pushing against a resistance in the direction 
of abduction (pushing out to the side).  The resistance will rotate at a constant speed up and 
down while you maintain contracting in the direction of abduction.  This test will be stopped 
after 2 minutes.  You will immediately perform an MVC and then run again for 
approximately 10 minutes.  In total, visit 2 will take approximately 2.5 hours. 
 
If you decide to come back for visit 3, you will again be outfitted with 39 reflective markers.  
We will test you hip abduction strength, have you run for approximately 30 minutes at 
around your 5k running pace, and then immediately test hip abduction strength again.  This 
will take approximately 1 hour. 
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COMPENSATION: You will be compensated $10 per hour, for a maximum total of $50 
if you complete all 3 visits.  Visit 1 = $15, Visit 2 = $25, and Visit 3 = $10. 
 
RISKS AND DISCOMFORTS: We expect that there will be no more risk for you during 
these tests than there normally is for you when outside of the laboratory.  Running in the 
laboratory may be slightly different than running outside requiring them to speed up and 
slow down quickly as well as navigate tight corners. While these conditions should not pose 
any risks or hazards, care will be taken to allow you to take breaks or cease data collection if 
needed.   
In order to place electrodes on your hip muscles, we will need to partially expose your 
buttocks and lateral thigh in order to properly palpate these muscles to place the electrodes 
on your skin.  This will be done in a separate room with the curtain pulled.  A researcher of 
the same sex as you will place the electrodes.  We realize that these areas can be sensitive 
for some subjects.  If you are uncomfortable with partially exposing these areas for electrode 
placement, it is probably best to not participate in this study. 
Occasionally, an individual may feel light-headed or dizzy from smelling the alcohol 
solution used to clean your skin.  If you feel light-headed at any time, please notify the 
investigators so that we can stop the procedure.  Additionally, the hypo-allergenic 
conducting gel can produce an allergic response, such as redness of itching, in some 
subjects.  If this occurs, it will be limited to the region of skin the gel is applied.  If you 
experience undue discomfort from this gel, please again notify the investigators. 
During the fatigue protocol, you will likely feel some discomfort, specifically in the muscles 
being fatigued.  This discomfort is expected and normal.  Additionally, some subjects may 
experience fatigue and/or soreness in the hip abductor muscles for up to 72 hours following 
the test.  Please let us know if you experience excessive discomfort or any level of pain 
throughout the study.  You are free to stop the test at any time without penalty for any 
reason.   
 
ADDITIONAL INFORMATION: Any information that is obtained in connection with this 
study and that can be identified with you will remain confidential and will not be shared 
without your permission. 
Subject identities will be kept confidential by coding the data as to study, subject 
pseudonyms, and collection date. The code list will be kept separate and secure from the 
actual data files.  
 
Your participation is completely voluntary. Your decision whether or not to participate will 
not affect your relationship with the Department of Human Physiology or University of 
Oregon. You do not waive any liability rights for personal injury by signing this form. In 
spite of all precautions, you might develop medical complications from participating in this 
study. If such complications arise, the researchers will assist you in obtaining appropriate 
medical treatment. In addition, if you are physically injured because of the project, you and 
your insurance company will have to pay your doctor bills. If you are a University of 
Oregon student or employee and are covered by a University of Oregon medical plan, that 
plan might have terms that apply to your injury. If you have any questions about your rights 
as a research subject, you can contact Research Compliance Services, 5237 University of 
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Oregon, Eugene, OR 97403, (541) 346- 2510. This office oversees the review of the 
research to protect your rights and is not involved with this study. 
 
If you decide to participate, you are free to withdraw your consent and discontinue 
participation at any time without penalty.  
 
If you have any questions, please feel free to contact JJ Hannigan, (541) 346-1033 or Dr. Li-
Shan Chou, (541) 346-3391, Department of Human Physiology, 112C Esslinger Hall, 
University of Oregon, Eugene OR, 97403-1240. You will be given a copy of this form to 
keep. Your signature indicates that you have read and understand the information provided 
above, that you willingly agree to participate, that you may withdraw your consent at any 
time and discontinue participation without penalty, that you will receive a copy of this form, 
and that you are not waiving any legal claims, rights or remedies. 
 
Name: ________________________________________ 
Signature: _____________________________________________ 
Date: ________________________________ 
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